Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings
•Chemotherapy induced peripheral neuropathy is a common progressive, and often irreversible, adverse effect of many chemotherapeutic agents.•Currently, there are no effective treatments to prevent or control CIPN and there is limited evidence of effective treatment for chronic CIPN.•There are new me...
Saved in:
| Published in | Critical reviews in oncology/hematology Vol. 145; p. 102831 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
01.01.2020
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | •Chemotherapy induced peripheral neuropathy is a common progressive, and often irreversible, adverse effect of many chemotherapeutic agents.•Currently, there are no effective treatments to prevent or control CIPN and there is limited evidence of effective treatment for chronic CIPN.•There are new mechanisms that need to be highlighted and examined in depth for use in developing effective therapies.
Chemotherapy-induced peripheral neuropathy (CIPN) is an adverse effect of chemotherapy that is frequently experienced by patients receiving treatment for cancer. CIPN is caused by many of the most commonly used chemotherapeutic agents, including taxanes, vinca alkaloids, and bortezomib. Pain and sensory abnormalities may persist for months, or even years after the cessation of chemotherapy. The management of CIPN is a significant challenge, as it is not possible to predict which patients will develop symptoms, the timing for the appearance of symptoms can develop anytime during the chemotherapy course, there are no early indications that warrant a reduction in the dosage to halt CIPN progression, and there are no drugs approved to prevent or alleviate CIPN. This review focuses on the etiology of CIPN and will highlight the various approaches developed for prevention and treatment. The goal is to guide studies to identify, test, and standardize approaches for managing CIPN. |
|---|---|
| AbstractList | •Chemotherapy induced peripheral neuropathy is a common progressive, and often irreversible, adverse effect of many chemotherapeutic agents.•Currently, there are no effective treatments to prevent or control CIPN and there is limited evidence of effective treatment for chronic CIPN.•There are new mechanisms that need to be highlighted and examined in depth for use in developing effective therapies.
Chemotherapy-induced peripheral neuropathy (CIPN) is an adverse effect of chemotherapy that is frequently experienced by patients receiving treatment for cancer. CIPN is caused by many of the most commonly used chemotherapeutic agents, including taxanes, vinca alkaloids, and bortezomib. Pain and sensory abnormalities may persist for months, or even years after the cessation of chemotherapy. The management of CIPN is a significant challenge, as it is not possible to predict which patients will develop symptoms, the timing for the appearance of symptoms can develop anytime during the chemotherapy course, there are no early indications that warrant a reduction in the dosage to halt CIPN progression, and there are no drugs approved to prevent or alleviate CIPN. This review focuses on the etiology of CIPN and will highlight the various approaches developed for prevention and treatment. The goal is to guide studies to identify, test, and standardize approaches for managing CIPN. Chemotherapy-induced peripheral neuropathy (CIPN) is an adverse effect of chemotherapy that is frequently experienced by patients receiving treatment for cancer. CIPN is caused by many of the most commonly used chemotherapeutic agents, including taxanes, vinca alkaloids, and bortezomib. Pain and sensory abnormalities may persist for months, or even years after the cessation of chemotherapy. The management of CIPN is a significant challenge, as it is not possible to predict which patients will develop symptoms, the timing for the appearance of symptoms can develop anytime during the chemotherapy course, there are no early indications that warrant a reduction in the dosage to halt CIPN progression, and there are no drugs approved to prevent or alleviate CIPN. This review focuses on the etiology of CIPN and will highlight the various approaches developed for prevention and treatment. The goal is to guide studies to identify, test, and standardize approaches for managing CIPN. |
| ArticleNumber | 102831 |
| Author | Ibrahim, Eiman Y. Ehrlich, Barbara E. |
| Author_xml | – sequence: 1 givenname: Eiman Y. orcidid: 0000-0002-7445-6540 surname: Ibrahim fullname: Ibrahim, Eiman Y. email: eiman.ibrahim@yale.edu – sequence: 2 givenname: Barbara E. orcidid: 0000-0001-9657-9704 surname: Ehrlich fullname: Ehrlich, Barbara E. email: barbara.ehrlich@yale.edu |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31783290$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkF1PwyAUhomZcR_6Fwx_oBMKpdQLk7n4lSzRi3lNCoWNZYOGdjP799JUp155BTnnPO85ecZg4LzTAECMphhhdrOZqmDboA_eqWmKcBHLKSf4DIwwz4sEUYYH8Y8oSjhN-RCMm2aDEKKU5RdgSHDOSVqgEXh_iynatdY76A1Ua73z7VqHsj4m1lV7pStY62DrrraFTu-Dr8t2fbyFMxhRqz86LmgVQ6CJiHWr5hKcm3Lb6KuvdwKWjw_L-XOyeH16mc8Wicpo1iaG55xikxOT4kpJWlQZoyYleUGoKjiqCOEqUzlF3CBppDScMZkpmZlcyoxMwF0fW-_lTlfdCfFIUQe7K8NR-NKKvx1n12LlD4IVPGW0C-B9gAq-aYI2JxYj0ZkWG_FjWnSmRW86ote_d5_Ab7Vx4L4f0FFA9BREo6x2UaiNtlpRefv_lk-CGZnp |
| CitedBy_id | crossref_primary_10_1007_s00520_022_06890_1 crossref_primary_10_1002_acn3_51426 crossref_primary_10_1016_j_apjon_2023_100198 crossref_primary_10_1016_j_tiv_2021_105233 crossref_primary_10_1002_ibra_12086 crossref_primary_10_3166_dea_2021_0178 crossref_primary_10_1016_j_advms_2020_04_001 crossref_primary_10_1007_s13311_020_00873_y crossref_primary_10_3390_cancers13246239 crossref_primary_10_1007_s00520_024_08680_3 crossref_primary_10_1089_acm_2020_0012 crossref_primary_10_3389_fpain_2022_912977 crossref_primary_10_17116_jnevro202312307119 crossref_primary_10_1111_fcp_12970 crossref_primary_10_3390_physiologia3040042 crossref_primary_10_1016_j_ceca_2023_102762 crossref_primary_10_1016_j_intimp_2022_108693 crossref_primary_10_2217_nnm_2021_0361 crossref_primary_10_3389_fphar_2021_774795 crossref_primary_10_3390_molecules26123577 crossref_primary_10_3390_cancers12092540 crossref_primary_10_1039_D3BM00120B crossref_primary_10_3389_fimmu_2021_642420 crossref_primary_10_1016_j_ceca_2020_102266 crossref_primary_10_1016_j_isci_2023_107778 crossref_primary_10_3390_ijms23179641 crossref_primary_10_3389_fpain_2022_864910 crossref_primary_10_3389_fonc_2021_781812 crossref_primary_10_3390_toxics11100848 crossref_primary_10_3390_pharmaceutics15122788 crossref_primary_10_4236_ym_2023_72013 crossref_primary_10_1007_s00520_021_06082_3 crossref_primary_10_3390_ijms241914430 crossref_primary_10_3389_fonc_2021_642382 crossref_primary_10_3389_fpain_2022_1100524 crossref_primary_10_3389_fnmol_2023_1130123 crossref_primary_10_3233_PPR_210511 crossref_primary_10_3390_cancers16030580 crossref_primary_10_1051_medsci_2020191 crossref_primary_10_2147_JPR_S275254 crossref_primary_10_3389_fonc_2024_1327318 crossref_primary_10_3389_fphar_2020_600037 crossref_primary_10_1007_s00520_023_08082_x crossref_primary_10_3390_ijms222111913 crossref_primary_10_3390_ijms24098359 crossref_primary_10_1016_j_ctrv_2022_102396 crossref_primary_10_3389_fphar_2023_1178421 crossref_primary_10_1007_s00228_022_03434_8 crossref_primary_10_1111_ijn_13094 crossref_primary_10_1002_tox_24035 crossref_primary_10_1186_s13046_021_02127_x crossref_primary_10_1007_s40265_022_01675_6 crossref_primary_10_1016_j_breast_2022_12_034 crossref_primary_10_1016_j_bpsc_2020_11_015 crossref_primary_10_1021_acs_jmedchem_1c01912 crossref_primary_10_1212_WNL_0000000000012300 crossref_primary_10_1371_journal_pone_0275648 crossref_primary_10_1177_1534735420943287 crossref_primary_10_1039_D2RA00993E crossref_primary_10_1016_j_ejon_2021_102025 crossref_primary_10_1186_s12885_021_08240_6 crossref_primary_10_1590_0034_7167_2022_0161 crossref_primary_10_5306_wjco_v12_i6_458 crossref_primary_10_1002_cbdv_202100415 crossref_primary_10_1007_s10549_020_05897_8 crossref_primary_10_1016_j_breast_2024_103763 crossref_primary_10_3390_life13020537 crossref_primary_10_1016_j_douler_2023_11_007 crossref_primary_10_1111_ajco_13923 crossref_primary_10_29328_journal_jnnd_1001093 crossref_primary_10_1111_jns_12544 crossref_primary_10_3390_curroncol28040273 crossref_primary_10_1007_s00520_021_06585_z crossref_primary_10_1007_s15015_020_2575_z crossref_primary_10_3390_ph16070959 crossref_primary_10_17116_jnevro20231230517 crossref_primary_10_1016_j_ynpai_2024_100152 crossref_primary_10_1016_j_cyto_2023_156370 crossref_primary_10_1590_0034_7167_2022_0161pt crossref_primary_10_1177_09645284221125421 crossref_primary_10_3390_pharmaceutics15030852 crossref_primary_10_3390_antiox11122387 crossref_primary_10_1007_s00520_023_07688_5 crossref_primary_10_37349_ent_2022_00020 crossref_primary_10_7475_kjan_2021_33_5_472 crossref_primary_10_1002_adhm_202400809 crossref_primary_10_1007_s13311_021_01142_2 crossref_primary_10_1080_08923973_2022_2141643 crossref_primary_10_1111_cbdd_14192 crossref_primary_10_1016_j_jphs_2021_03_001 crossref_primary_10_3389_fncel_2022_836931 crossref_primary_10_1186_s13046_021_02141_z crossref_primary_10_1155_2021_8815206 |
| Cites_doi | 10.1002/mus.22092 10.1172/JCI96160 10.1200/JCO.2013.54.0914 10.1002/pbc.26677 10.1074/jbc.M112.385070 10.1007/s00520-015-3063-4 10.1182/blood-2009-08-239046 10.1007/s11060-014-1632-x 10.1074/jbc.M111.265751 10.1158/1055-9965.EPI-18-0167 10.1200/JCO.2014.58.8533 10.2174/157015906776359568 10.1146/annurev.cellbio.16.1.89 10.1016/j.expneurol.2016.11.015 10.1007/s12272-013-0057-y 10.1002/ana.24951 10.1001/archderm.1994.01690010070009 10.1001/jama.2013.2813 10.4161/cbt.4.8.1867 10.1016/j.ctrv.2009.10.006 10.1186/1471-2407-12-355 10.1016/B978-0-444-53502-3.00031-8 10.1158/1055-9965.EPI-10-0437 10.1073/pnas.0701546104 10.1016/j.ejca.2005.06.030 10.1001/jamaneurol.2016.0383 10.1177/1049909111412539 10.2165/00002018-199513040-00003 10.1073/pnas.232693499 10.2174/1570159X15666170915143217 10.1016/j.ejon.2019.03.002 10.1016/j.critrevonc.2008.01.008 10.1111/j.1742-7843.2008.00351.x 10.1517/14740338.2011.543417 10.1038/nrclinonc.2009.128 10.3109/10428194.2012.728597 10.1172/JCI22466 10.1158/1078-0432.CCR-12-0761 10.1634/theoncologist.2017-0235 10.5306/wjco.v8.i4.329 10.1038/nrclinonc.2016.206 10.1007/s00520-010-0911-0 10.1097/00008571-200110000-00006 10.1159/000143223 10.1111/j.1365-2141.2005.05914.x 10.1093/annonc/mds329 10.3389/fonc.2019.00296 10.1097/CIN.0000000000000320 10.1093/jnci/djz011 10.1093/annonc/mdt018 10.1177/030089160509100206 10.1096/fj.12-214643 10.1016/j.expneurol.2011.08.016 10.1158/1535-7163.MCT-08-0840 10.1158/1078-0432.CCR-10-1950 10.1371/journal.pone.0072995 10.2217/pgs.09.82 10.1016/j.tox.2011.10.019 10.1016/j.jns.2007.05.023 10.1016/j.ctrv.2014.04.004 10.1002/glia.21065 10.1016/S1470-2045(10)70206-0 10.1186/1756-8722-2-36 10.1038/s41523-018-0057-7 10.1007/s10549-010-1034-5 10.1016/j.jfo.2013.03.007 10.1158/1078-0432.CCR-03-0561 10.1002/ana.24004 10.1016/j.neulet.2014.10.014 10.2174/092986708786848569 10.3390/toxics3020198 10.1016/j.critrevonc.2011.04.012 10.1056/NEJM199504133321507 10.1097/CCO.0000000000000349 10.1007/s00228-011-1007-6 10.1200/JCO.2007.11.6699 10.5603/GP.a2018.0034 10.1371/journal.pone.0221787 10.1073/pnas.0607240103 10.4103/1673-5374.198986 10.1007/s00520-017-3772-y 10.1007/s10147-015-0810-y 10.2217/pmt-2018-0020 10.1038/sj.bjc.6601012 10.3109/07357909209032783 10.1016/j.bbamcr.2018.05.005 10.1016/j.pain.2014.09.020 10.1097/CIN.0000000000000242 10.1002/phar.1642 10.1200/jco.2013.31.15_suppl.cra1008 10.1016/j.exphem.2014.03.005 10.1186/s40880-017-0196-5 10.1182/blood-2010-02-268862 10.1007/s00520-016-3329-5 10.18632/oncotarget.23467 10.1111/ajco.12822 10.1016/S1470-2045(11)70131-0 10.1002/cncr.23008 10.1097/CAD.0b013e32832a2dc1 10.3389/fnmol.2017.00174 10.1038/srep28861 |
| ContentType | Journal Article |
| Copyright | 2019 Elsevier B.V. Copyright © 2019 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2019 Elsevier B.V. – notice: Copyright © 2019 Elsevier B.V. All rights reserved. |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM |
| DOI | 10.1016/j.critrevonc.2019.102831 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
| DatabaseTitleList | MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1879-0461 |
| EndPage | 102831 |
| ExternalDocumentID | 10_1016_j_critrevonc_2019_102831 31783290 S1040842819302161 |
| Genre | Journal Article Review |
| GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: P30 DK090744 – fundername: NIDDK NIH HHS grantid: P01 DK057751 – fundername: NCATS NIH HHS grantid: UL1 TR001863 |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29F 4.4 457 4CK 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABBQC ABFNM ABJNI ABLJU ABLVK ABMAC ABMZM ABXDB ABYKQ ACDAQ ACGFS ACIUM ACRLP ADEZE ADMUD AEBSH AEKER AENEX AEVXI AFFNX AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HMK HMO HVGLF HZ~ IHE J1W KOM LCYCR M29 M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SEL SES SEW SSH SSZ T5K UDS W2D WUQ Z5R ~G- AKRWK CGR CUY CVF ECM EIF NPM AAXKI AAYXX CITATION 5PM |
| ID | FETCH-LOGICAL-c545t-f87841f73f21dcb49d564f237934c980d338c5c7408f0bfbbf866b5cb5f7bb53 |
| IEDL.DBID | .~1 |
| ISSN | 1040-8428 |
| IngestDate | Tue Sep 17 21:01:10 EDT 2024 Thu Sep 12 19:05:28 EDT 2024 Thu May 23 23:45:46 EDT 2024 Fri Feb 23 02:47:37 EST 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Chemotherapy Oxaliplatin Paclitaxel Neuropathy CIPN Vinca alkaloids Taxanes Cisplatin |
| Language | English |
| License | Copyright © 2019 Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c545t-f87841f73f21dcb49d564f237934c980d338c5c7408f0bfbbf866b5cb5f7bb53 |
| Notes | EYI and BEE conceived the project, EYI wrote the first draft and both authors edited the manuscript. AUTHOR CONTRIBUTIONS |
| ORCID | 0000-0002-7445-6540 0000-0001-9657-9704 |
| OpenAccessLink | https://europepmc.org/articles/pmc6982645?pdf=render |
| PMID | 31783290 |
| PageCount | 1 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6982645 crossref_primary_10_1016_j_critrevonc_2019_102831 pubmed_primary_31783290 elsevier_sciencedirect_doi_10_1016_j_critrevonc_2019_102831 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-01-01 |
| PublicationDateYYYYMMDD | 2020-01-01 |
| PublicationDate_xml | – month: 01 year: 2020 text: 2020-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Critical reviews in oncology/hematology |
| PublicationTitleAlternate | Crit Rev Oncol Hematol |
| PublicationYear | 2020 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Daily, Aquilante (bib0250) 2009; 10 Zhu, Chen, Mi, Zhou, Reed, Hoke (bib0595) 2013; 74 Mauri, Kamposioras, Tsali, Bristianou, Valachis, Karathanasi, Georgiou, Polyzos (bib0225) 2010; 36 Bolomsky, Schreder, Meissner, Hose, Ludwig, Pfeifer, Zojer (bib0430) 2014; 42 Hu, Mi, Wu, Wang, Mao-Ying (bib0505) 2019; 17 Jemal, Center, DeSantis, Ward (bib0005) 2010; 19 Albers, Chaudhry, Cavaletti, Donehower (bib0100) 2019; 48 Cavaletti, Cornblath, Merkies, Postma, Rossi, Frigeni, Alberti, Bruna, Velasco, Argyriou (bib0125) 2012; 24 Romero-Sandoval, Asbill, Paige, Byrd-Glover (bib0540) 2015; 35 Richardson, Weller, Lonial, Jakubowiak, Jagannath, Raje, Avigan, Xie, Ghobrial, Schlossman (bib0395) 2010; 116 Smith, Acharya, Desai, Figg, Sparreboom (bib0195) 2005; 4 Leblanc, Sprowl, Alberti, Chiorazzi, Arnold, Gibson, Hong, Pioso, Chen, Huang, Chodisetty, Costa, Florea, de Bruijn, Mathijssen, Reinbolt, Lustberg, Sucheston-Campbell, Cavaletti, Sparreboom, Hu (bib0200) 2018; 128 Gay, Hayman, Lacy, Buadi, Gertz, Kumar, Dispenzieri, Mikhael, Bergsagel, Dingli, Reeder, Lust, Russell, Roy, Zeldenrust, Witzig, Fonseca, Kyle, Greipp, Stewart, Rajkumar (bib0450) 2010; 115 Maayan, Ron, Shiran, Ronen, Pamela, Moshe, Noam (bib0535) 2019; 26 Kotla, Goel, Nischal, Heuck, Vivek, Das, Verma (bib0420) 2009; 2 Benbow, Mann, Keeler, Fan, Hodsdon, Lolis, DeGray, Ehrlich (bib0295) 2012; 287 Moore, Wilkinson, Altan, Toki, Carvajal-Hausdorf, McGuire, Ehrlich, Rimm (bib0575) 2018; 4 Nazir, AlFutaisi, Zacharia, Elshinawy, Mevada, Alrawas, Khater, Jaju, Wali (bib0300) 2017; 64 Kolb, Smith, Singleton, Beck, Stoddard, Brown, Mooney (bib0090) 2016; 73 Kim, Jin, Kwon, Woo, Ko, Park, Park, Kang (bib0490) 2018; 14 Pike, Birnbaum, Muehlenbein, Pohl, Natale (bib0035) 2012; 2012 Bergmann, Gréen, Brasch-Andersen, Mirza, Herrstedt, Hølund, Du Bois, Damkier, Vach, Brosen (bib0265) 2011; 67 Magnowska, Izycka, Kapola-Czyz, Romala, Lorek, Spaczynski, Nowak-Markwitz (bib0485) 2018; 89 Pachman, Qin, Seisler, Smith, Beutler, Ta, Lafky, Wagner-Johnston, Ruddy, Dakhil, Staff, Grothey, Loprinzi (bib0060) 2015; 33 Fukuda, Li, Segal (bib0330) 2017; 11 Tan, Luo, Zheng, Tian, He, Chen, Zeng, Lv (bib0230) 2017; 36 Carozzi, Canta, Chiorazzi (bib0020) 2015; 596 Manasanch, Orlowski (bib0400) 2017; 14 Smith, Pang, Cirrincione, Fleishman, Paskett, Ahles, Bressler, Fadul, Knox, Le-Lindqwister, Gilman, Shapiro (bib0470) 2013; 309 Barton, Wos, Qin, Mattar, Green, Lanier, Bearden, Kugler, Hoff, Reddy, Rowland, Riepl, Christensen, Loprinzi (bib0530) 2011; 19 Boehmerle, Splittgerber, Lazarus, McKenzie, Johnston, Austin, Ehrlich (bib0165) 2006; 103 Ge, Jakobsson (bib0580) 2019; 9 Batta, Trechot, Cloche, George, Angioi (bib0305) 2013; 36 Staff, Grisold, Grisold, Windebank (bib0320) 2017; 81 Argyriou, Koltzenburg, Polychronopoulos, Papapetropoulos, Kalofonos (bib0015) 2008; 66 Majithia, Temkin, Ruddy, Beutler, Hershman, Loprinzi (bib0080) 2016; 24 Boeckel, Ehrlich (bib0170) 2018; 1865 Schiff, Wen, van den Bent (bib0360) 2009; 6 Majithia, Loprinzi, Smith (bib0520) 2016; 30 Knoerl, Dudley, Smith, Bridges, Kanzawa-Lee, Lavoie Smith (bib0115) 2017; 35 Maestri, De Pasquale Ceratti, Cundari, Zanna, Cortesi, Crinò (bib0560) 2005; 91 Carozzi, Renn, Bardini, Fazio, Chiorazzi, Meregalli, Oggioni, Shanks, Quartu, Serra, Sala, Cavaletti, Dorsey (bib0405) 2013; 8 Glasmacher, Hahn, Hoffmann, Naumann, Goldschmidt, von Lilienfeld-Toal, Orlopp, Schmidt-Wolf, Gorschlüter (bib0410) 2006; 132 Zheng, Xiao, Bennett (bib0160) 2011; 232 Jaggi, Singh (bib0030) 2012; 291 Rizzo, Spaggiari, Indelli, Lelli, Baricordi, Rimessi, Ferlini (bib0260) 2010; 124 Boyette-Davis, Hou, Abdi, Dougherty (bib0140) 2018; 8 Park, Krishnan, Lin, Goldstein, Friedlander, Kiernan (bib0025) 2008; 15 Canta, Pozzi, Carozzi (bib0290) 2015; 3 Boehmerle, Zhang, Sivula, Heidrich, Lee, Jordt, Ehrlich (bib0185) 2007; 104 Ochonisky, Verroust, Bastuji-Garin, Gherardi, Revuz (bib0445) 1994; 130 Alberti, Cavaletti (bib0130) 2014 Green, Söderkvist, Rosenberg, Mirghani, Rymark, Lundqvist, Peterson (bib0255) 2009; 104 Ghoreishi, Esfahani, Djazayeri, Djalali, Golestan, Ayromlou, Hashemzade, Jafarabadi, Montazeri, Keshavarz (bib0555) 2012; 12 Gadgil, Ergün, van den Heuvel, van der Wal, Scheffer, Hooijmans (bib0045) 2019; 14 de Andrade, Jacobsen Teixeira, Galhardoni, Ferreira, Braz Mileno, Scisci, Zandonai, Teixeira, Saragiotto, Silva, Raicher, Cury, Macarenco, Otto Heise, Wilson Iervolino Brotto, Andrade de Mello, Zini Megale, Henrique Curti Dourado, Mendes Bahia, Lilian Rodrigues, Parravano, Tizue Fukushima, Lefaucheur, Bouhassira, Sobroza, Riechelmann, Hoff, Valerio da Silva, Chile, Dale, Nebuloni, Senna, Brentani, Pagano, de Souza (bib0500) 2017; 22 Tofthagen, Kip, Passmore, Loy, Berry (bib0120) 2016; 34 Wadia, Stolar, Grens, Ehrlich, Chao (bib0585) 2018; 9 Zanville, Nudelman, Smith, Von Ah, McDonald, Champion, Saykin (bib0095) 2016; 24 Jamieson, Liu, Hsu, Baguley, McKeage (bib0335) 2003; 88 Jongen, Broijl, Sonneveld (bib0435) 2015; 121 Ong (bib0515) 2008; 74 Argyriou, Bruna, Marmiroli, Cavaletti (bib0110) 2012; 82 McKeage (bib0350) 1995; 13 Scagliotti, Vokes (bib0325) 2018 Dixit, Dhingra, Kaushal (bib0310) 2012; 60 Mielke, Sparreboom, Mross (bib0050) 2006; 42 Kanat, Ertas, Caner (bib0340) 2017; 8 Hershman, Lacchetti, Dworkin, Lavoie Smith, Bleeker, Cavaletti, Chauhan, Gavin, Lavino, Lustberg (bib0135) 2014; 32 Cavaletti, Alberti, Marmiroli (bib0270) 2011; 12 Seretny, Currie, Sena, Ramnarine, Grant, MacLeod, Colvin, Fallon (bib0055) 2014; 155 Mo, Erdelyi, Szigeti-Buck, Benbow, Ehrlich (bib0205) 2012; 26 Saarto, Wiffen (bib0455) 2007 Zhu, Carozzi, Reed, Mi, Marmiroli, Cavaletti, Hoke (bib0590) 2016; 6 Ibrahim, Busaidy (bib0415) 2017; 29 Hirayama, Ishitani, Sato, Iyama, Takada, Murase, Kuroda, Nagamachi, Konuma, Fujimi, Sagawa, Ono, Horiguchi, Terui, Koike, Kusakabe, Sato, Takimoto, Kobune, Kato (bib0475) 2015; 20 Scripture, Figg, Sparreboom (bib0215) 2006; 4 Filosto, Rossi, Pelizzari, Buzio, Tentorio, Broglio, Mancuso, Rinaldi, Scarpelli, Padovani (bib0390) 2007; 263 Moudi, Go, Yien, Nazre (bib0275) 2013; 4 Zhu, Kortuem, Stewart (bib0425) 2013; 54 Balayssac, Ferrier, Descoeur, Ling, Pezet, Eschalier, Authier (bib0210) 2011; 10 van den Heuvel, van der Wal, Smedes, Radema, van Alfen, Vissers (bib0525) 2017; 2017 Wiernik, Yeap, Vogl, Kaplan, Comis, Falkson, Davis, Fazzini, Cheuvart, Horton (bib0550) 1992; 10 Kelley, Fehrenbacher (bib0065) 2017; 12 Broyl, Corthals, Jongen, van der Holt, Kuiper, de Knegt, van Duin, el Jarari, Bertsch, Lokhorst (bib0370) 2010; 11 Newton (bib0345) 2012; 105 Matsumura, Yokoyama, Hirakawa, Shigeto, Futagami, Mizunuma (bib0155) 2014; 10 Milla, Airoldi, Weber, Drescher, Jaehde, Cattel (bib0545) 2009; 20 Starobova, Vetter (bib0315) 2017; 10 Koh, Undie, Kabbani, Levenson, Goldman-Rakic, Lidow (bib0565) 2003; 100 Downing (bib0280) 2000; 16 Wani, Chakrabarty, Shibata (bib0440) 2017; 30 Izgu, Metin, Karadas, Ozdemir, Cetin, Demirci (bib0600) 2019; 40 Pei, Dai, Grant (bib0375) 2004; 10 Dai, Zeldin, Blaisdell, Chanas, Coulter, Ghanayem, Goldstein (bib0245) 2001; 11 Bril, England, Franklin, Backonja, Cohen, Del Toro, Feldman, Iverson, Perkins, Russell, Zochodne (bib0460) 2011; 43 Benbow, DeGray, Ehrlich (bib0180) 2011; 286 Song, Min, Suh, Jung, Hahn, Im, Lee (bib0070) 2017; 25 Seidman, Berry, Cirrincione, Harris, Muss, Marcom, Gipson, Burstein, Lake, Shapiro (bib0220) 2008; 26 McCrary, Goldstein, Boyle, Cox, Grimison, Kiernan, Krishnan, Lewis, Webber, Baron-Hay, Horvath, Park (bib0105) 2017; 25 Schlecker, Boehmerle, Jeromin, DeGray, Varshney, Sharma, Szigeti-Buck, Ehrlich (bib0175) 2006; 116 Hershman, Lacchetti, Dworkin, Lavoie Smith, Bleeker, Cavaletti, Chauhan, Gavin, Lavino, Lustberg, Paice, Schneider, Smith, Smith, Terstriep, Wagner-Johnston, Bak, Loprinzi (bib0075) 2014; 32 Beijers, Jongen, Vreugdenhil (bib0365) 2012; 70 Kukkar, Bali, Singh, Jaggi (bib0480) 2013; 36 Arastu-Kapur, Anderl, Kraus, Parlati, Shenk, Lee, Muchamuel, Bennett, Driessen, Ball, Kirk (bib0380) 2011; 17 Mishra, Bhatnagar, Goyal, Rana, Upadhya (bib0495) 2012; 29 Rowinsky, Donehower (bib0145) 1995; 332 Hertz, Roy, Motsinger-Reif, Drobish, Clark, McLeod, Carey, Dees (bib0240) 2013; 24 Ferguson, Wilcken, Vagg, Ghersi, Nowak (bib0010) 2007; 4 de Graan, Lancaster, Obaidat, Hagenbuch, Elens, Friberg, de Bruijn, Hu, Gibson, Bruun, Corydon, Mikkelsen, Walker, Du, Loos, van Schaik, Baker, Mathijssen, Sparreboom (bib0190) 2012; 18 Dorsey, Kleckner, Barton, Mustian, O’Mara, St. Germain, Cavaletti, Danhauer, Hershman, Hohmann, Hoke, Hopkins, Kelly, Loprinzi, McLeod, Mohile, Paice, Rowland, Salvemini, Segal, Smith, Stevens, Janelsins (bib0040) 2019; 111 Gornstein, Schwarz (bib0150) 2017; 288 Smith, Pang, Cirrincione, Fleishman, Paskett, Ahles, Bressler, Fadul, Knox, Le-Lindqwister, Gilman, Shapiro (bib0465) 2013; 309 Albers, Chaudhry, Cavaletti, Donehower (bib0085) 2007 Budd, Barlow, Moore, Hobday, Stewart, Isaacs, Salim, Cho, Rinn, Albain (bib0235) 2013 Miltenburg, Boogerd (bib0285) 2014; 40 Rao, Michalak, Sloan, Loprinzi, Soori, Nikcevich, Warner, Novotny, Kutteh, Wong (bib0510) 2007; 110 McWhinney, Goldberg, McLeod (bib0355) 2009; 8 Schuette, Moore, Robert, Taddei, Ehrlich (bib0570) 2018; 27 Shin, Jang, Lee, Jung, Suh, Seo, Park (bib0385) 2010; 58 Park (10.1016/j.critrevonc.2019.102831_bib0025) 2008; 15 Wadia (10.1016/j.critrevonc.2019.102831_bib0585) 2018; 9 Boeckel (10.1016/j.critrevonc.2019.102831_bib0170) 2018; 1865 Hershman (10.1016/j.critrevonc.2019.102831_bib0075) 2014; 32 Rowinsky (10.1016/j.critrevonc.2019.102831_bib0145) 1995; 332 Schlecker (10.1016/j.critrevonc.2019.102831_bib0175) 2006; 116 Leblanc (10.1016/j.critrevonc.2019.102831_bib0200) 2018; 128 Zhu (10.1016/j.critrevonc.2019.102831_bib0590) 2016; 6 Magnowska (10.1016/j.critrevonc.2019.102831_bib0485) 2018; 89 Benbow (10.1016/j.critrevonc.2019.102831_bib0180) 2011; 286 Bergmann (10.1016/j.critrevonc.2019.102831_bib0265) 2011; 67 Albers (10.1016/j.critrevonc.2019.102831_bib0085) 2007 Kotla (10.1016/j.critrevonc.2019.102831_bib0420) 2009; 2 Maayan (10.1016/j.critrevonc.2019.102831_bib0535) 2019; 26 Arastu-Kapur (10.1016/j.critrevonc.2019.102831_bib0380) 2011; 17 Pike (10.1016/j.critrevonc.2019.102831_bib0035) 2012; 2012 Pei (10.1016/j.critrevonc.2019.102831_bib0375) 2004; 10 Moudi (10.1016/j.critrevonc.2019.102831_bib0275) 2013; 4 Manasanch (10.1016/j.critrevonc.2019.102831_bib0400) 2017; 14 de Andrade (10.1016/j.critrevonc.2019.102831_bib0500) 2017; 22 Smith (10.1016/j.critrevonc.2019.102831_bib0465) 2013; 309 Knoerl (10.1016/j.critrevonc.2019.102831_bib0115) 2017; 35 Alberti (10.1016/j.critrevonc.2019.102831_bib0130) 2014 Seretny (10.1016/j.critrevonc.2019.102831_bib0055) 2014; 155 Benbow (10.1016/j.critrevonc.2019.102831_bib0295) 2012; 287 Hertz (10.1016/j.critrevonc.2019.102831_bib0240) 2013; 24 Cavaletti (10.1016/j.critrevonc.2019.102831_bib0125) 2012; 24 Carozzi (10.1016/j.critrevonc.2019.102831_bib0405) 2013; 8 Majithia (10.1016/j.critrevonc.2019.102831_bib0080) 2016; 24 Hershman (10.1016/j.critrevonc.2019.102831_bib0135) 2014; 32 Hu (10.1016/j.critrevonc.2019.102831_bib0505) 2019; 17 Majithia (10.1016/j.critrevonc.2019.102831_bib0520) 2016; 30 Zanville (10.1016/j.critrevonc.2019.102831_bib0095) 2016; 24 Gadgil (10.1016/j.critrevonc.2019.102831_bib0045) 2019; 14 Cavaletti (10.1016/j.critrevonc.2019.102831_bib0270) 2011; 12 Smith (10.1016/j.critrevonc.2019.102831_bib0195) 2005; 4 Argyriou (10.1016/j.critrevonc.2019.102831_bib0110) 2012; 82 Broyl (10.1016/j.critrevonc.2019.102831_bib0370) 2010; 11 Kukkar (10.1016/j.critrevonc.2019.102831_bib0480) 2013; 36 McCrary (10.1016/j.critrevonc.2019.102831_bib0105) 2017; 25 Budd (10.1016/j.critrevonc.2019.102831_bib0235) 2013 Schiff (10.1016/j.critrevonc.2019.102831_bib0360) 2009; 6 Schuette (10.1016/j.critrevonc.2019.102831_bib0570) 2018; 27 Argyriou (10.1016/j.critrevonc.2019.102831_bib0015) 2008; 66 Scripture (10.1016/j.critrevonc.2019.102831_bib0215) 2006; 4 Ghoreishi (10.1016/j.critrevonc.2019.102831_bib0555) 2012; 12 Balayssac (10.1016/j.critrevonc.2019.102831_bib0210) 2011; 10 Fukuda (10.1016/j.critrevonc.2019.102831_bib0330) 2017; 11 McKeage (10.1016/j.critrevonc.2019.102831_bib0350) 1995; 13 Dixit (10.1016/j.critrevonc.2019.102831_bib0310) 2012; 60 Tan (10.1016/j.critrevonc.2019.102831_bib0230) 2017; 36 Smith (10.1016/j.critrevonc.2019.102831_bib0470) 2013; 309 Zhu (10.1016/j.critrevonc.2019.102831_bib0425) 2013; 54 Kanat (10.1016/j.critrevonc.2019.102831_bib0340) 2017; 8 Ong (10.1016/j.critrevonc.2019.102831_bib0515) 2008; 74 Shin (10.1016/j.critrevonc.2019.102831_bib0385) 2010; 58 Jongen (10.1016/j.critrevonc.2019.102831_bib0435) 2015; 121 Rao (10.1016/j.critrevonc.2019.102831_bib0510) 2007; 110 Canta (10.1016/j.critrevonc.2019.102831_bib0290) 2015; 3 Zhu (10.1016/j.critrevonc.2019.102831_bib0595) 2013; 74 Albers (10.1016/j.critrevonc.2019.102831_bib0100) 2019; 48 Mauri (10.1016/j.critrevonc.2019.102831_bib0225) 2010; 36 McWhinney (10.1016/j.critrevonc.2019.102831_bib0355) 2009; 8 Miltenburg (10.1016/j.critrevonc.2019.102831_bib0285) 2014; 40 Filosto (10.1016/j.critrevonc.2019.102831_bib0390) 2007; 263 Staff (10.1016/j.critrevonc.2019.102831_bib0320) 2017; 81 Hirayama (10.1016/j.critrevonc.2019.102831_bib0475) 2015; 20 Zheng (10.1016/j.critrevonc.2019.102831_bib0160) 2011; 232 Mishra (10.1016/j.critrevonc.2019.102831_bib0495) 2012; 29 Song (10.1016/j.critrevonc.2019.102831_bib0070) 2017; 25 Rizzo (10.1016/j.critrevonc.2019.102831_bib0260) 2010; 124 Jamieson (10.1016/j.critrevonc.2019.102831_bib0335) 2003; 88 Starobova (10.1016/j.critrevonc.2019.102831_bib0315) 2017; 10 Boehmerle (10.1016/j.critrevonc.2019.102831_bib0165) 2006; 103 Richardson (10.1016/j.critrevonc.2019.102831_bib0395) 2010; 116 Wiernik (10.1016/j.critrevonc.2019.102831_bib0550) 1992; 10 Izgu (10.1016/j.critrevonc.2019.102831_bib0600) 2019; 40 Tofthagen (10.1016/j.critrevonc.2019.102831_bib0120) 2016; 34 Milla (10.1016/j.critrevonc.2019.102831_bib0545) 2009; 20 de Graan (10.1016/j.critrevonc.2019.102831_bib0190) 2012; 18 Ge (10.1016/j.critrevonc.2019.102831_bib0580) 2019; 9 Dorsey (10.1016/j.critrevonc.2019.102831_bib0040) 2019; 111 Gay (10.1016/j.critrevonc.2019.102831_bib0450) 2010; 115 Newton (10.1016/j.critrevonc.2019.102831_bib0345) 2012; 105 Ibrahim (10.1016/j.critrevonc.2019.102831_bib0415) 2017; 29 Downing (10.1016/j.critrevonc.2019.102831_bib0280) 2000; 16 Moore (10.1016/j.critrevonc.2019.102831_bib0575) 2018; 4 Daily (10.1016/j.critrevonc.2019.102831_bib0250) 2009; 10 Wani (10.1016/j.critrevonc.2019.102831_bib0440) 2017; 30 Saarto (10.1016/j.critrevonc.2019.102831_bib0455) 2007 Bolomsky (10.1016/j.critrevonc.2019.102831_bib0430) 2014; 42 Green (10.1016/j.critrevonc.2019.102831_bib0255) 2009; 104 Mielke (10.1016/j.critrevonc.2019.102831_bib0050) 2006; 42 Boehmerle (10.1016/j.critrevonc.2019.102831_bib0185) 2007; 104 Matsumura (10.1016/j.critrevonc.2019.102831_bib0155) 2014; 10 Jaggi (10.1016/j.critrevonc.2019.102831_bib0030) 2012; 291 Scagliotti (10.1016/j.critrevonc.2019.102831_bib0325) 2018 Kolb (10.1016/j.critrevonc.2019.102831_bib0090) 2016; 73 Pachman (10.1016/j.critrevonc.2019.102831_bib0060) 2015; 33 Koh (10.1016/j.critrevonc.2019.102831_bib0565) 2003; 100 Mo (10.1016/j.critrevonc.2019.102831_bib0205) 2012; 26 Maestri (10.1016/j.critrevonc.2019.102831_bib0560) 2005; 91 Kim (10.1016/j.critrevonc.2019.102831_bib0490) 2018; 14 Nazir (10.1016/j.critrevonc.2019.102831_bib0300) 2017; 64 Gornstein (10.1016/j.critrevonc.2019.102831_bib0150) 2017; 288 Romero-Sandoval (10.1016/j.critrevonc.2019.102831_bib0540) 2015; 35 Carozzi (10.1016/j.critrevonc.2019.102831_bib0020) 2015; 596 Batta (10.1016/j.critrevonc.2019.102831_bib0305) 2013; 36 Dai (10.1016/j.critrevonc.2019.102831_bib0245) 2001; 11 Glasmacher (10.1016/j.critrevonc.2019.102831_bib0410) 2006; 132 Ochonisky (10.1016/j.critrevonc.2019.102831_bib0445) 1994; 130 Bril (10.1016/j.critrevonc.2019.102831_bib0460) 2011; 43 van den Heuvel (10.1016/j.critrevonc.2019.102831_bib0525) 2017; 2017 Boyette-Davis (10.1016/j.critrevonc.2019.102831_bib0140) 2018; 8 Seidman (10.1016/j.critrevonc.2019.102831_bib0220) 2008; 26 Kelley (10.1016/j.critrevonc.2019.102831_bib0065) 2017; 12 Jemal (10.1016/j.critrevonc.2019.102831_bib0005) 2010; 19 Barton (10.1016/j.critrevonc.2019.102831_bib0530) 2011; 19 Ferguson (10.1016/j.critrevonc.2019.102831_bib0010) 2007; 4 Beijers (10.1016/j.critrevonc.2019.102831_bib0365) 2012; 70 |
| References_xml | – volume: 35 start-page: 917 year: 2015 end-page: 925 ident: bib0540 article-title: Peripherally restricted cannabinoids for the treatment of pain publication-title: Pharmacotherapy. contributor: fullname: Byrd-Glover – volume: 4 start-page: 165 year: 2006 end-page: 172 ident: bib0215 article-title: Peripheral neuropathy induced by paclitaxel: recent insights and future perspectives publication-title: Curr. Neuropharmacol. contributor: fullname: Sparreboom – volume: 116 start-page: 679 year: 2010 end-page: 686 ident: bib0395 article-title: Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma publication-title: Blood contributor: fullname: Schlossman – volume: 20 start-page: 866 year: 2015 end-page: 871 ident: bib0475 article-title: Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial publication-title: Int. J. Clin. Oncol. contributor: fullname: Kato – volume: 132 start-page: 584 year: 2006 end-page: 593 ident: bib0410 article-title: A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma publication-title: Br. J. Haematol. contributor: fullname: Gorschlüter – volume: 67 start-page: 693 year: 2011 end-page: 700 ident: bib0265 article-title: Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer publication-title: Eur. J. Clin. Pharmacol. contributor: fullname: Brosen – volume: 6 start-page: 596 year: 2009 ident: bib0360 article-title: Neurological adverse effects caused by cytotoxic and targeted therapies publication-title: Nat. Rev. Clin. Oncol. contributor: fullname: van den Bent – volume: 14 start-page: 417 year: 2017 ident: bib0400 article-title: Proteasome inhibitors in cancer therapy publication-title: Nat. Rev. Clin. Oncol. contributor: fullname: Orlowski – volume: 32 start-page: 1941 year: 2014 end-page: 1967 ident: bib0075 article-title: Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: american Society of Clinical Oncology clinical practice guideline publication-title: J. Clin. Oncol. contributor: fullname: Loprinzi – volume: 8 start-page: 329 year: 2017 end-page: 335 ident: bib0340 article-title: Platinum-induced neurotoxicity: a review of possible mechanisms publication-title: World J. Clin. Oncol. contributor: fullname: Caner – volume: 4 start-page: 1231 year: 2013 end-page: 1235 ident: bib0275 article-title: Vinca alkaloids publication-title: Int. J. Prev. Med. contributor: fullname: Nazre – volume: 2017 year: 2017 ident: bib0525 article-title: Intravenous lidocaine: old-school drug, new purpose-reduction of intractable pain in patients with chemotherapy induced peripheral publication-title: Neuropathy contributor: fullname: Vissers – volume: 6 start-page: 28861 year: 2016 ident: bib0590 article-title: Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity publication-title: Sci. Rep. contributor: fullname: Hoke – volume: 30 start-page: 1020 year: 2016 end-page: 1029 ident: bib0520 article-title: New practical approaches to chemotherapy-induced neuropathic pain: prevention, assessment, and treatment publication-title: Oncology (Williston Park, N.Y.) contributor: fullname: Smith – volume: 121 start-page: 229 year: 2015 end-page: 237 ident: bib0435 article-title: Chemotherapy-induced peripheral neuropathies in hematological malignancies publication-title: J. Neurooncol. contributor: fullname: Sonneveld – volume: 24 start-page: 1472 year: 2013 end-page: 1478 ident: bib0240 article-title: CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel† publication-title: Ann. Oncol. contributor: fullname: Dees – volume: 58 start-page: 1961 year: 2010 end-page: 1976 ident: bib0385 article-title: Pathological adaptive responses of Schwann cells to endoplasmic reticulum stress in bortezomib-induced peripheral neuropathy publication-title: Glia. contributor: fullname: Park – volume: 263 start-page: 40 year: 2007 end-page: 43 ident: bib0390 article-title: A high-dose bortezomib neuropathy with sensory ataxia and myelin involvement publication-title: J. Neurol. Sci. contributor: fullname: Padovani – volume: 60 start-page: 56 year: 2012 end-page: 58 ident: bib0310 article-title: Vincristine induced cranial neuropathy publication-title: J. Assoc. Physicians India contributor: fullname: Kaushal – volume: 42 start-page: 24 year: 2006 end-page: 30 ident: bib0050 article-title: Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes publication-title: Eur. J. Cancer contributor: fullname: Mross – volume: 1865 start-page: 1660 year: 2018 end-page: 1667 ident: bib0170 article-title: NCS-1 is a regulator of calcium signaling in health and disease publication-title: Biochim. et biophys. acta Mol. Cell Res. contributor: fullname: Ehrlich – volume: 110 start-page: 2110 year: 2007 end-page: 2118 ident: bib0510 article-title: Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3) publication-title: Cancer. contributor: fullname: Wong – volume: 24 start-page: 4779 year: 2016 end-page: 4789 ident: bib0095 article-title: Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment publication-title: Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. contributor: fullname: Saykin – volume: 43 start-page: 910 year: 2011 end-page: 917 ident: bib0460 article-title: Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation publication-title: Muscle Nerve contributor: fullname: Zochodne – volume: 332 start-page: 1004 year: 1995 end-page: 1014 ident: bib0145 article-title: Paclitaxel (taxol) publication-title: N. Engl. J. Med. contributor: fullname: Donehower – volume: 29 start-page: 177 year: 2012 end-page: 182 ident: bib0495 article-title: A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study publication-title: Am. J. Hosp. Palliat. Care contributor: fullname: Upadhya – volume: 128 start-page: 816 year: 2018 end-page: 825 ident: bib0200 article-title: OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity publication-title: J. Clin. Invest. contributor: fullname: Hu – start-page: Cd005454 year: 2007 ident: bib0455 article-title: Antidepressants for neuropathic pain publication-title: Cochrane Database Syst. Rev. contributor: fullname: Wiffen – volume: 8 start-page: 363 year: 2018 end-page: 375 ident: bib0140 article-title: An updated understanding of the mechanisms involved in chemotherapy-induced neuropathy publication-title: Pain Manag. contributor: fullname: Dougherty – volume: 4 start-page: 6 year: 2018 ident: bib0575 article-title: An assessment of neuronal calcium sensor-1 and response to neoadjuvant chemotherapy in breast cancer patients publication-title: NPJ Breast Cancer contributor: fullname: Rimm – start-page: Cd005228 year: 2007 ident: bib0085 article-title: Interventions for preventing neuropathy caused by cisplatin and related compounds publication-title: Cochrane Database Syst. Rev. contributor: fullname: Donehower – volume: 19 start-page: 833 year: 2011 end-page: 841 ident: bib0530 article-title: A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA publication-title: Support. Care Cancer contributor: fullname: Loprinzi – volume: 91 start-page: 135 year: 2005 end-page: 138 ident: bib0560 article-title: A pilot study on the effect of acetyl-L-carnitine in paclitaxel-and cisplatin-induced peripheral neuropathy publication-title: Tumori. contributor: fullname: Crinò – volume: 104 start-page: 11103 year: 2007 end-page: 11108 ident: bib0185 article-title: Chronic exposure to paclitaxel diminishes phosphoinositide signaling by calpain-mediated neuronal calcium sensor-1 degradation publication-title: Proc. Natl. Acad. Sci. contributor: fullname: Ehrlich – volume: 10 start-page: 407 year: 2011 end-page: 417 ident: bib0210 article-title: Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence publication-title: Expert Opin. Drug Saf. contributor: fullname: Authier – volume: 4 year: 2007 ident: bib0010 article-title: Taxanes for adjuvant treatment of early breast cancer publication-title: Cochrane Database Syst. Rev. contributor: fullname: Nowak – volume: 9 start-page: 7322 year: 2018 end-page: 7331 ident: bib0585 article-title: The prevention of chemotherapy induced peripheral neuropathy by concurrent treatment with drugs used for bipolar disease: a retrospective chart analysis in human cancer patients publication-title: Oncotarget. contributor: fullname: Chao – volume: 24 start-page: 454 year: 2012 end-page: 462 ident: bib0125 article-title: The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings publication-title: Ann. Oncol. contributor: fullname: Argyriou – volume: 26 start-page: 1642 year: 2008 end-page: 1649 ident: bib0220 article-title: Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840 publication-title: J. Clin. Oncol. contributor: fullname: Shapiro – volume: 64 year: 2017 ident: bib0300 article-title: Vincristine-induced neuropathy in pediatric patients with acute lymphoblastic leukemia in Oman: frequent autonomic and more severe cranial nerve involvement publication-title: Pediatr. Blood Cancer contributor: fullname: Wali – volume: 286 start-page: 34575 year: 2011 end-page: 34582 ident: bib0180 article-title: Protection of neuronal calcium sensor 1 protein in cells treated with paclitaxel publication-title: J. Biol. Chem. contributor: fullname: Ehrlich – volume: 74 start-page: 893 year: 2013 end-page: 904 ident: bib0595 article-title: Ethoxyquin prevents chemotherapy-induced neurotoxicity via Hsp90 modulation publication-title: Ann. Neurol. contributor: fullname: Hoke – volume: 66 start-page: 218 year: 2008 end-page: 228 ident: bib0015 article-title: Peripheral nerve damage associated with administration of taxanes in patients with cancer publication-title: Crit. Rev. Oncol. Hematol. contributor: fullname: Kalofonos – volume: 40 start-page: 872 year: 2014 end-page: 882 ident: bib0285 article-title: Chemotherapy-induced neuropathy: a comprehensive survey publication-title: Cancer Treat. Rev. contributor: fullname: Boogerd – volume: 36 start-page: 683 year: 2013 end-page: 686 ident: bib0305 article-title: [Vincristine-induced unilateral ptosis: case report and review of the literature] publication-title: J. Fr. Ophtalmol. contributor: fullname: Angioi – volume: 10 start-page: 1489 year: 2009 end-page: 1510 ident: bib0250 article-title: Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies publication-title: Pharmacogenomics contributor: fullname: Aquilante – volume: 15 start-page: 3081 year: 2008 end-page: 3094 ident: bib0025 article-title: Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies publication-title: Curr. Med. Chem. contributor: fullname: Kiernan – volume: 14 start-page: e448 year: 2018 end-page: e454 ident: bib0490 article-title: Efficacy and safety of oxycodone/naloxone as add-on therapy to gabapentin or pregabalin for the management of chemotherapy-induced peripheral neuropathy in Korea publication-title: Asia. J. Clin. Oncol. contributor: fullname: Kang – volume: 19 start-page: 1893 year: 2010 end-page: 1907 ident: bib0005 article-title: Global patterns of cancer incidence and mortality rates and trends publication-title: Cancer Epidemiol. Prevent. Biomark. contributor: fullname: Ward – volume: 11 start-page: 597 year: 2001 end-page: 607 ident: bib0245 article-title: Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid publication-title: Pharmacogenetics contributor: fullname: Goldstein – volume: 42 start-page: 516 year: 2014 end-page: 525 ident: bib0430 article-title: Immunomodulatory drugs thalidomide and lenalidomide affect osteoblast differentiation of human bone marrow stromal cells in vitro publication-title: Exp. Hematol. contributor: fullname: Zojer – volume: 111 start-page: 531 year: 2019 end-page: 537 ident: bib0040 article-title: The National Cancer Institute Clinical Trials Planning Meeting for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy publication-title: JNCI contributor: fullname: Janelsins – volume: 73 start-page: 860 year: 2016 end-page: 866 ident: bib0090 article-title: The association of chemotherapy-induced peripheral neuropathy symptoms and the risk of falling publication-title: JAMA Neurol. contributor: fullname: Mooney – volume: 104 start-page: 130 year: 2009 end-page: 137 ident: bib0255 article-title: Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer publication-title: Basic Clin. Pharmacol. Toxicol. contributor: fullname: Peterson – volume: 89 start-page: 200 year: 2018 end-page: 204 ident: bib0485 article-title: Effectiveness of gabapentin pharmacotherapy in chemotherapy-induced peripheral neuropathy publication-title: Ginekol. Pol. contributor: fullname: Nowak-Markwitz – volume: 2 start-page: 36 year: 2009 ident: bib0420 article-title: Mechanism of action of lenalidomide in hematological malignancies publication-title: J. Hematol. Oncol. contributor: fullname: Verma – volume: 11 year: 2017 ident: bib0330 article-title: A mechanistic understanding of axon degeneration in chemotherapy-induced peripheral neuropathy publication-title: Front. Neurosci. contributor: fullname: Segal – volume: 26 start-page: 1 year: 2019 end-page: 10 ident: bib0535 article-title: Management of peripheral neuropathy induced by chemotherapy publication-title: Curr. Med. Chem. contributor: fullname: Noam – volume: 10 start-page: 174- year: 2017 ident: bib0315 article-title: Pathophysiology of chemotherapy-induced peripheral neuropathy publication-title: Front. Mol. Neurosci. contributor: fullname: Vetter – year: 2013 ident: bib0235 article-title: S0221: comparison of two schedules of paclitaxel as adjuvant therapy for breast cancer publication-title: Am. Soc. Clin. Oncol. contributor: fullname: Albain – volume: 3 start-page: 198 year: 2015 end-page: 223 ident: bib0290 article-title: Mitochondrial dysfunction in chemotherapy-induced peripheral neuropathy (CIPN) publication-title: Toxics. contributor: fullname: Carozzi – volume: 291 start-page: 1 year: 2012 end-page: 9 ident: bib0030 article-title: Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy publication-title: Toxicology. contributor: fullname: Singh – volume: 82 start-page: 51 year: 2012 end-page: 77 ident: bib0110 article-title: Chemotherapy-induced peripheral neurotoxicity (CIPN): an update publication-title: Crit. Rev. Oncol. Hematol. contributor: fullname: Cavaletti – volume: 103 start-page: 18356 year: 2006 end-page: 18361 ident: bib0165 article-title: Paclitaxel induces calcium oscillations via an inositol 1, 4, 5-trisphosphate receptor and neuronal calcium sensor 1-dependent mechanism publication-title: Proc. Natl. Acad. Sci. contributor: fullname: Ehrlich – volume: 105 start-page: 903 year: 2012 end-page: 916 ident: bib0345 article-title: Neurological complications of chemotherapy to the central nervous system publication-title: Handb. Clin. Neurol. contributor: fullname: Newton – volume: 309 start-page: 1359 year: 2013 end-page: 1367 ident: bib0470 article-title: Alliance for Clinical Trials in O. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial publication-title: JAMA. contributor: fullname: Shapiro – volume: 40 start-page: 36 year: 2019 end-page: 43 ident: bib0600 article-title: Prevention of chemotherapy-induced peripheral neuropathy with classical massage in breast cancer patients receiving paclitaxel: an assessor-blinded randomized controlled trial publication-title: Eur. J. Oncol. Nurs. contributor: fullname: Demirci – volume: 12 start-page: 72 year: 2017 ident: bib0065 article-title: Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage publication-title: Neural Regen. Res. contributor: fullname: Fehrenbacher – volume: 130 start-page: 66 year: 1994 end-page: 69 ident: bib0445 article-title: Thalidomide neuropathy incidence and clinicoelectrophysiologic findings in 42 patients publication-title: JAMA Dermatol. contributor: fullname: Revuz – volume: 155 start-page: 2461 year: 2014 end-page: 2470 ident: bib0055 article-title: Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis publication-title: Pain. contributor: fullname: Fallon – volume: 13 start-page: 228 year: 1995 end-page: 244 ident: bib0350 article-title: Comparative adverse effect profiles of platinum drugs publication-title: Drug Saf. contributor: fullname: McKeage – volume: 11 start-page: 1057 year: 2010 end-page: 1065 ident: bib0370 article-title: Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial publication-title: Lancet Oncol. contributor: fullname: Lokhorst – volume: 54 start-page: 683 year: 2013 end-page: 687 ident: bib0425 article-title: Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma publication-title: Leukemia Lymphoma contributor: fullname: Stewart – volume: 115 start-page: 1343 year: 2010 end-page: 1350 ident: bib0450 article-title: Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients publication-title: Blood. contributor: fullname: Rajkumar – volume: 36 start-page: 69 year: 2010 end-page: 74 ident: bib0225 article-title: Overall survival benefit for weekly vs. Three-weekly taxanes regimens in advanced breast cancer: a meta-analysis publication-title: Cancer Treat. Rev. contributor: fullname: Polyzos – start-page: 301 year: 2014 end-page: 322 ident: bib0130 article-title: Management of Side Effects in the Personalized Medicine Era: Chemotherapy-induced Peripheral Neuropathy. Pharmacogenomics in Drug Discovery and Development contributor: fullname: Cavaletti – volume: 14 year: 2019 ident: bib0045 article-title: A systematic summary and comparison of animal models for chemotherapy induced (peripheral) neuropathy (CIPN) publication-title: PLoS One contributor: fullname: Hooijmans – volume: 8 start-page: e72995-e year: 2013 ident: bib0405 article-title: Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse publication-title: PLoS One contributor: fullname: Dorsey – volume: 33 start-page: 3416 year: 2015 end-page: 3422 ident: bib0060 article-title: Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance) publication-title: J. Clin. Oncol. contributor: fullname: Loprinzi – volume: 25 start-page: 2241 year: 2017 end-page: 2248 ident: bib0070 article-title: Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast publication-title: cancer contributor: fullname: Lee – volume: 36 start-page: 27 year: 2017 ident: bib0230 article-title: Weekly taxane–anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial publication-title: Chin. J. Cancer contributor: fullname: Lv – volume: 88 start-page: 1942 year: 2003 end-page: 1947 ident: bib0335 article-title: Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity publication-title: Br. J. Cancer contributor: fullname: McKeage – volume: 12 start-page: 1151 year: 2011 end-page: 1161 ident: bib0270 article-title: Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics publication-title: Lancet Oncol. contributor: fullname: Marmiroli – volume: 29 start-page: 151 year: 2017 end-page: 158 ident: bib0415 article-title: Treatment and surveillance of advanced, metastatic iodine-resistant differentiated thyroid cancer publication-title: Curr. Opin. Oncol. contributor: fullname: Busaidy – volume: 596 start-page: 90 year: 2015 end-page: 107 ident: bib0020 article-title: Chemotherapy-induced peripheral neuropathy: what do we know about mechanisms? publication-title: Neurosci. Lett. contributor: fullname: Chiorazzi – volume: 18 start-page: 4433 year: 2012 end-page: 4440 ident: bib0190 article-title: Influence of polymorphic OATP1B-Type carriers on the disposition of Docetaxel publication-title: Clin. Cancer Res. contributor: fullname: Sparreboom – volume: 10 start-page: 1 year: 1992 end-page: 9 ident: bib0550 article-title: Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: a study of the Eastern Cooperative Oncology Group publication-title: Cancer Invest. contributor: fullname: Horton – volume: 12 start-page: 355 year: 2012 ident: bib0555 article-title: Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial publication-title: BMC Cancer contributor: fullname: Keshavarz – volume: 30 start-page: 1622 year: 2017 end-page: 1628 ident: bib0440 article-title: The dihydroxy metabolite of the teratogen thalidomide causes oxidative DNA publication-title: Damage contributor: fullname: Shibata – volume: 309 start-page: 1359 year: 2013 end-page: 1367 ident: bib0465 article-title: Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial publication-title: JAMA. contributor: fullname: Shapiro – start-page: 512 year: 2018 end-page: 524 ident: bib0325 article-title: 51 - adjuvant and neoadjuvant chemotherapy for early-stage nonsmall cell lung cancer publication-title: IASLC Thoracic Oncology contributor: fullname: Vokes – volume: 20 start-page: 396 year: 2009 end-page: 402 ident: bib0545 article-title: Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity publication-title: Anticancer Drugs contributor: fullname: Cattel – volume: 32 start-page: 1941 year: 2014 end-page: 1967 ident: bib0135 article-title: Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: american Society of Clinical Oncology clinical practice guideline publication-title: J. Clin. Oncol. contributor: fullname: Lustberg – volume: 288 start-page: 153 year: 2017 end-page: 166 ident: bib0150 article-title: Neurotoxic mechanisms of paclitaxel are local to the distal axon and independent of transport defects publication-title: Exp. Neurol. contributor: fullname: Schwarz – volume: 287 start-page: 37907 year: 2012 end-page: 37916 ident: bib0295 article-title: Inhibition of paclitaxel-induced decreases in calcium signaling publication-title: J. Biol. Chem. contributor: fullname: Ehrlich – volume: 36 start-page: 237 year: 2013 end-page: 251 ident: bib0480 article-title: Implications and mechanism of action of gabapentin in neuropathic pain publication-title: Arch. Pharm. Res. contributor: fullname: Jaggi – volume: 25 start-page: 3485 year: 2017 end-page: 3493 ident: bib0105 article-title: Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey publication-title: Support. Care Cancer contributor: fullname: Park – volume: 10 start-page: 3839 year: 2004 end-page: 3852 ident: bib0375 article-title: Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors publication-title: Clin. Cancer Res. contributor: fullname: Grant – volume: 17 start-page: 184 year: 2019 end-page: 196 ident: bib0505 article-title: Prevention and treatment for chemotherapy-induced peripheral neuropathy: therapies based on CIPN mechanisms publication-title: Curr. Neuropharmacol. contributor: fullname: Mao-Ying – volume: 16 start-page: 89 year: 2000 end-page: 111 ident: bib0280 article-title: Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics publication-title: Annu. Rev. Cell Dev. Biol. contributor: fullname: Downing – volume: 2012 year: 2012 ident: bib0035 article-title: Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer publication-title: Chemother. Res. Pract. contributor: fullname: Natale – volume: 22 start-page: 1154 year: 2017 end-page: e105 ident: bib0500 article-title: Pregabalin for the prevention of oxaliplatin-induced painful neuropathy: a randomized, double-blind trial publication-title: Oncologist contributor: fullname: de Souza – volume: 26 start-page: 4696 year: 2012 end-page: 4709 ident: bib0205 article-title: Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment publication-title: FASEB J. contributor: fullname: Ehrlich – volume: 24 start-page: 1439 year: 2016 end-page: 1447 ident: bib0080 article-title: National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons publication-title: Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. contributor: fullname: Loprinzi – volume: 232 start-page: 154 year: 2011 end-page: 161 ident: bib0160 article-title: Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy publication-title: Exp. Neurol. contributor: fullname: Bennett – volume: 34 start-page: 322 year: 2016 end-page: 329 ident: bib0120 article-title: Usability and acceptability of a web-based program for chemotherapy-induced peripheral neuropathy publication-title: Comput. Inform. Nurs. contributor: fullname: Berry – volume: 81 start-page: 772 year: 2017 end-page: 781 ident: bib0320 article-title: Chemotherapy-induced peripheral neuropathy: a current review publication-title: Ann. Neurol. contributor: fullname: Windebank – volume: 8 start-page: 10 year: 2009 end-page: 16 ident: bib0355 article-title: Platinum neurotoxicity pharmacogenetics publication-title: Mol. Cancer Ther. contributor: fullname: McLeod – volume: 35 start-page: 201 year: 2017 end-page: 211 ident: bib0115 article-title: Pilot testing a web-based system for the assessment and management of chemotherapy-induced peripheral neuropathy publication-title: Comput. Inform. Nurs. contributor: fullname: Lavoie Smith – volume: 100 start-page: 313 year: 2003 end-page: 317 ident: bib0565 article-title: Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients publication-title: Proc Natl Acad Sci U S A. contributor: fullname: Lidow – volume: 10 year: 2014 ident: bib0155 article-title: The prophylactic effects of a traditional Japanese medicine, goshajinkigan, on paclitaxel-induced peripheral neuropathy and its mechanism of action publication-title: Mol. Pain contributor: fullname: Mizunuma – volume: 9 start-page: 296- year: 2019 ident: bib0580 article-title: Systems biology understanding of the effects of Lithium on Cancer publication-title: Front. Oncol. contributor: fullname: Jakobsson – volume: 17 start-page: 2734 year: 2011 end-page: 2743 ident: bib0380 article-title: Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events publication-title: Clin. Cancer Res. contributor: fullname: Kirk – volume: 74 start-page: 72 year: 2008 end-page: 75 ident: bib0515 article-title: Controlled-release oxycodone in the treatment of neuropathic pain of nonmalignant and malignant causes publication-title: Oncology. contributor: fullname: Ong – volume: 27 start-page: 1091 year: 2018 end-page: 1100 ident: bib0570 article-title: Hepatocellular carcinoma outcome is predicted by expression of neuronal calcium sensor 1 publication-title: Cancer Epidemiol. Biomarkers Prev. contributor: fullname: Ehrlich – volume: 124 start-page: 593 year: 2010 end-page: 598 ident: bib0260 article-title: Association of CYP1B1 with hypersensitivity induced by taxane therapy in breast cancer patients publication-title: Breast Cancer Res. Treat. contributor: fullname: Ferlini – volume: 48 year: 2019 ident: bib0100 publication-title: Interventions for Preventing Neuropathy Caused by Cisplatin and Related Compounds. Department of Neurology contributor: fullname: Donehower – volume: 116 start-page: 1668 year: 2006 end-page: 1674 ident: bib0175 article-title: Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithium publication-title: J. Clin. Invest. contributor: fullname: Ehrlich – volume: 4 start-page: 815 year: 2005 end-page: 818 ident: bib0195 article-title: Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel publication-title: Cancer Biol. Ther. contributor: fullname: Sparreboom – volume: 70 start-page: 18 year: 2012 end-page: 25 ident: bib0365 article-title: Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies publication-title: Neth. J. Med. contributor: fullname: Vreugdenhil – volume: 43 start-page: 910 issue: 6 year: 2011 ident: 10.1016/j.critrevonc.2019.102831_bib0460 article-title: Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation publication-title: Muscle Nerve doi: 10.1002/mus.22092 contributor: fullname: Bril – volume: 128 start-page: 816 issue: 2 year: 2018 ident: 10.1016/j.critrevonc.2019.102831_bib0200 article-title: OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity publication-title: J. Clin. Invest. doi: 10.1172/JCI96160 contributor: fullname: Leblanc – volume: 32 start-page: 1941 issue: 18 year: 2014 ident: 10.1016/j.critrevonc.2019.102831_bib0135 article-title: Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: american Society of Clinical Oncology clinical practice guideline publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2013.54.0914 contributor: fullname: Hershman – volume: 64 issue: 12 year: 2017 ident: 10.1016/j.critrevonc.2019.102831_bib0300 article-title: Vincristine-induced neuropathy in pediatric patients with acute lymphoblastic leukemia in Oman: frequent autonomic and more severe cranial nerve involvement publication-title: Pediatr. Blood Cancer doi: 10.1002/pbc.26677 contributor: fullname: Nazir – volume: 287 start-page: 37907 issue: 45 year: 2012 ident: 10.1016/j.critrevonc.2019.102831_bib0295 article-title: Inhibition of paclitaxel-induced decreases in calcium signaling publication-title: J. Biol. Chem. doi: 10.1074/jbc.M112.385070 contributor: fullname: Benbow – volume: 24 start-page: 1439 issue: 3 year: 2016 ident: 10.1016/j.critrevonc.2019.102831_bib0080 article-title: National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons publication-title: Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. doi: 10.1007/s00520-015-3063-4 contributor: fullname: Majithia – volume: 115 start-page: 1343 issue: 7 year: 2010 ident: 10.1016/j.critrevonc.2019.102831_bib0450 article-title: Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients publication-title: Blood. doi: 10.1182/blood-2009-08-239046 contributor: fullname: Gay – start-page: 301 year: 2014 ident: 10.1016/j.critrevonc.2019.102831_bib0130 contributor: fullname: Alberti – volume: 121 start-page: 229 issue: 2 year: 2015 ident: 10.1016/j.critrevonc.2019.102831_bib0435 article-title: Chemotherapy-induced peripheral neuropathies in hematological malignancies publication-title: J. Neurooncol. doi: 10.1007/s11060-014-1632-x contributor: fullname: Jongen – volume: 286 start-page: 34575 issue: 40 year: 2011 ident: 10.1016/j.critrevonc.2019.102831_bib0180 article-title: Protection of neuronal calcium sensor 1 protein in cells treated with paclitaxel publication-title: J. Biol. Chem. doi: 10.1074/jbc.M111.265751 contributor: fullname: Benbow – volume: 27 start-page: 1091 issue: 9 year: 2018 ident: 10.1016/j.critrevonc.2019.102831_bib0570 article-title: Hepatocellular carcinoma outcome is predicted by expression of neuronal calcium sensor 1 publication-title: Cancer Epidemiol. Biomarkers Prev. doi: 10.1158/1055-9965.EPI-18-0167 contributor: fullname: Schuette – volume: 33 start-page: 3416 issue: 30 year: 2015 ident: 10.1016/j.critrevonc.2019.102831_bib0060 article-title: Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance) publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2014.58.8533 contributor: fullname: Pachman – volume: 4 start-page: 165 issue: 2 year: 2006 ident: 10.1016/j.critrevonc.2019.102831_bib0215 article-title: Peripheral neuropathy induced by paclitaxel: recent insights and future perspectives publication-title: Curr. Neuropharmacol. doi: 10.2174/157015906776359568 contributor: fullname: Scripture – volume: 16 start-page: 89 issue: 1 year: 2000 ident: 10.1016/j.critrevonc.2019.102831_bib0280 article-title: Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics publication-title: Annu. Rev. Cell Dev. Biol. doi: 10.1146/annurev.cellbio.16.1.89 contributor: fullname: Downing – volume: 288 start-page: 153 year: 2017 ident: 10.1016/j.critrevonc.2019.102831_bib0150 article-title: Neurotoxic mechanisms of paclitaxel are local to the distal axon and independent of transport defects publication-title: Exp. Neurol. doi: 10.1016/j.expneurol.2016.11.015 contributor: fullname: Gornstein – volume: 2012 year: 2012 ident: 10.1016/j.critrevonc.2019.102831_bib0035 article-title: Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer publication-title: Chemother. Res. Pract. contributor: fullname: Pike – volume: 26 start-page: 1 year: 2019 ident: 10.1016/j.critrevonc.2019.102831_bib0535 article-title: Management of peripheral neuropathy induced by chemotherapy publication-title: Curr. Med. Chem. contributor: fullname: Maayan – volume: 36 start-page: 237 issue: 3 year: 2013 ident: 10.1016/j.critrevonc.2019.102831_bib0480 article-title: Implications and mechanism of action of gabapentin in neuropathic pain publication-title: Arch. Pharm. Res. doi: 10.1007/s12272-013-0057-y contributor: fullname: Kukkar – volume: 81 start-page: 772 issue: 6 year: 2017 ident: 10.1016/j.critrevonc.2019.102831_bib0320 article-title: Chemotherapy-induced peripheral neuropathy: a current review publication-title: Ann. Neurol. doi: 10.1002/ana.24951 contributor: fullname: Staff – volume: 130 start-page: 66 issue: 1 year: 1994 ident: 10.1016/j.critrevonc.2019.102831_bib0445 article-title: Thalidomide neuropathy incidence and clinicoelectrophysiologic findings in 42 patients publication-title: JAMA Dermatol. doi: 10.1001/archderm.1994.01690010070009 contributor: fullname: Ochonisky – volume: 309 start-page: 1359 issue: 13 year: 2013 ident: 10.1016/j.critrevonc.2019.102831_bib0470 article-title: Alliance for Clinical Trials in O. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial publication-title: JAMA. doi: 10.1001/jama.2013.2813 contributor: fullname: Smith – volume: 4 start-page: 815 issue: 8 year: 2005 ident: 10.1016/j.critrevonc.2019.102831_bib0195 article-title: Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel publication-title: Cancer Biol. Ther. doi: 10.4161/cbt.4.8.1867 contributor: fullname: Smith – volume: 36 start-page: 69 issue: 1 year: 2010 ident: 10.1016/j.critrevonc.2019.102831_bib0225 article-title: Overall survival benefit for weekly vs. Three-weekly taxanes regimens in advanced breast cancer: a meta-analysis publication-title: Cancer Treat. Rev. doi: 10.1016/j.ctrv.2009.10.006 contributor: fullname: Mauri – volume: 12 start-page: 355 issue: 1 year: 2012 ident: 10.1016/j.critrevonc.2019.102831_bib0555 article-title: Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial publication-title: BMC Cancer doi: 10.1186/1471-2407-12-355 contributor: fullname: Ghoreishi – volume: 105 start-page: 903 year: 2012 ident: 10.1016/j.critrevonc.2019.102831_bib0345 article-title: Neurological complications of chemotherapy to the central nervous system publication-title: Handb. Clin. Neurol. doi: 10.1016/B978-0-444-53502-3.00031-8 contributor: fullname: Newton – volume: 60 start-page: 56 year: 2012 ident: 10.1016/j.critrevonc.2019.102831_bib0310 article-title: Vincristine induced cranial neuropathy publication-title: J. Assoc. Physicians India contributor: fullname: Dixit – volume: 19 start-page: 1893 issue: 8 year: 2010 ident: 10.1016/j.critrevonc.2019.102831_bib0005 article-title: Global patterns of cancer incidence and mortality rates and trends publication-title: Cancer Epidemiol. Prevent. Biomark. doi: 10.1158/1055-9965.EPI-10-0437 contributor: fullname: Jemal – volume: 104 start-page: 11103 issue: 26 year: 2007 ident: 10.1016/j.critrevonc.2019.102831_bib0185 article-title: Chronic exposure to paclitaxel diminishes phosphoinositide signaling by calpain-mediated neuronal calcium sensor-1 degradation publication-title: Proc. Natl. Acad. Sci. doi: 10.1073/pnas.0701546104 contributor: fullname: Boehmerle – volume: 42 start-page: 24 issue: 1 year: 2006 ident: 10.1016/j.critrevonc.2019.102831_bib0050 article-title: Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes publication-title: Eur. J. Cancer doi: 10.1016/j.ejca.2005.06.030 contributor: fullname: Mielke – volume: 73 start-page: 860 issue: 7 year: 2016 ident: 10.1016/j.critrevonc.2019.102831_bib0090 article-title: The association of chemotherapy-induced peripheral neuropathy symptoms and the risk of falling publication-title: JAMA Neurol. doi: 10.1001/jamaneurol.2016.0383 contributor: fullname: Kolb – volume: 32 start-page: 1941 issue: 18 year: 2014 ident: 10.1016/j.critrevonc.2019.102831_bib0075 article-title: Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: american Society of Clinical Oncology clinical practice guideline publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2013.54.0914 contributor: fullname: Hershman – volume: 29 start-page: 177 issue: 3 year: 2012 ident: 10.1016/j.critrevonc.2019.102831_bib0495 article-title: A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study publication-title: Am. J. Hosp. Palliat. Care doi: 10.1177/1049909111412539 contributor: fullname: Mishra – volume: 2017 year: 2017 ident: 10.1016/j.critrevonc.2019.102831_bib0525 article-title: Intravenous lidocaine: old-school drug, new purpose-reduction of intractable pain in patients with chemotherapy induced peripheral publication-title: Neuropathy contributor: fullname: van den Heuvel – volume: 30 start-page: 1622 issue: 8 year: 2017 ident: 10.1016/j.critrevonc.2019.102831_bib0440 article-title: The dihydroxy metabolite of the teratogen thalidomide causes oxidative DNA publication-title: Damage contributor: fullname: Wani – volume: 13 start-page: 228 issue: 4 year: 1995 ident: 10.1016/j.critrevonc.2019.102831_bib0350 article-title: Comparative adverse effect profiles of platinum drugs publication-title: Drug Saf. doi: 10.2165/00002018-199513040-00003 contributor: fullname: McKeage – volume: 100 start-page: 313 issue: 1 year: 2003 ident: 10.1016/j.critrevonc.2019.102831_bib0565 article-title: Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients publication-title: Proc Natl Acad Sci U S A. doi: 10.1073/pnas.232693499 contributor: fullname: Koh – volume: 309 start-page: 1359 issue: 13 year: 2013 ident: 10.1016/j.critrevonc.2019.102831_bib0465 article-title: Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial publication-title: JAMA. doi: 10.1001/jama.2013.2813 contributor: fullname: Smith – volume: 17 start-page: 184 issue: 2 year: 2019 ident: 10.1016/j.critrevonc.2019.102831_bib0505 article-title: Prevention and treatment for chemotherapy-induced peripheral neuropathy: therapies based on CIPN mechanisms publication-title: Curr. Neuropharmacol. doi: 10.2174/1570159X15666170915143217 contributor: fullname: Hu – volume: 70 start-page: 18 issue: 1 year: 2012 ident: 10.1016/j.critrevonc.2019.102831_bib0365 article-title: Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies publication-title: Neth. J. Med. contributor: fullname: Beijers – volume: 40 start-page: 36 year: 2019 ident: 10.1016/j.critrevonc.2019.102831_bib0600 article-title: Prevention of chemotherapy-induced peripheral neuropathy with classical massage in breast cancer patients receiving paclitaxel: an assessor-blinded randomized controlled trial publication-title: Eur. J. Oncol. Nurs. doi: 10.1016/j.ejon.2019.03.002 contributor: fullname: Izgu – volume: 66 start-page: 218 issue: 3 year: 2008 ident: 10.1016/j.critrevonc.2019.102831_bib0015 article-title: Peripheral nerve damage associated with administration of taxanes in patients with cancer publication-title: Crit. Rev. Oncol. Hematol. doi: 10.1016/j.critrevonc.2008.01.008 contributor: fullname: Argyriou – volume: 104 start-page: 130 issue: 2 year: 2009 ident: 10.1016/j.critrevonc.2019.102831_bib0255 article-title: Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer publication-title: Basic Clin. Pharmacol. Toxicol. doi: 10.1111/j.1742-7843.2008.00351.x contributor: fullname: Green – volume: 10 start-page: 407 issue: 3 year: 2011 ident: 10.1016/j.critrevonc.2019.102831_bib0210 article-title: Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence publication-title: Expert Opin. Drug Saf. doi: 10.1517/14740338.2011.543417 contributor: fullname: Balayssac – volume: 10 issue: 61 year: 2014 ident: 10.1016/j.critrevonc.2019.102831_bib0155 article-title: The prophylactic effects of a traditional Japanese medicine, goshajinkigan, on paclitaxel-induced peripheral neuropathy and its mechanism of action publication-title: Mol. Pain contributor: fullname: Matsumura – volume: 6 start-page: 596 year: 2009 ident: 10.1016/j.critrevonc.2019.102831_bib0360 article-title: Neurological adverse effects caused by cytotoxic and targeted therapies publication-title: Nat. Rev. Clin. Oncol. doi: 10.1038/nrclinonc.2009.128 contributor: fullname: Schiff – volume: 48 year: 2019 ident: 10.1016/j.critrevonc.2019.102831_bib0100 contributor: fullname: Albers – volume: 54 start-page: 683 issue: 4 year: 2013 ident: 10.1016/j.critrevonc.2019.102831_bib0425 article-title: Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma publication-title: Leukemia Lymphoma doi: 10.3109/10428194.2012.728597 contributor: fullname: Zhu – volume: 116 start-page: 1668 issue: 6 year: 2006 ident: 10.1016/j.critrevonc.2019.102831_bib0175 article-title: Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithium publication-title: J. Clin. Invest. doi: 10.1172/JCI22466 contributor: fullname: Schlecker – volume: 18 start-page: 4433 issue: 16 year: 2012 ident: 10.1016/j.critrevonc.2019.102831_bib0190 article-title: Influence of polymorphic OATP1B-Type carriers on the disposition of Docetaxel publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-12-0761 contributor: fullname: de Graan – volume: 22 start-page: 1154 issue: 10 year: 2017 ident: 10.1016/j.critrevonc.2019.102831_bib0500 article-title: Pregabalin for the prevention of oxaliplatin-induced painful neuropathy: a randomized, double-blind trial publication-title: Oncologist doi: 10.1634/theoncologist.2017-0235 contributor: fullname: de Andrade – volume: 8 start-page: 329 issue: 4 year: 2017 ident: 10.1016/j.critrevonc.2019.102831_bib0340 article-title: Platinum-induced neurotoxicity: a review of possible mechanisms publication-title: World J. Clin. Oncol. doi: 10.5306/wjco.v8.i4.329 contributor: fullname: Kanat – volume: 14 start-page: 417 year: 2017 ident: 10.1016/j.critrevonc.2019.102831_bib0400 article-title: Proteasome inhibitors in cancer therapy publication-title: Nat. Rev. Clin. Oncol. doi: 10.1038/nrclinonc.2016.206 contributor: fullname: Manasanch – volume: 19 start-page: 833 issue: 6 year: 2011 ident: 10.1016/j.critrevonc.2019.102831_bib0530 article-title: A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA publication-title: Support. Care Cancer doi: 10.1007/s00520-010-0911-0 contributor: fullname: Barton – volume: 11 start-page: 597 issue: 7 year: 2001 ident: 10.1016/j.critrevonc.2019.102831_bib0245 article-title: Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid publication-title: Pharmacogenetics doi: 10.1097/00008571-200110000-00006 contributor: fullname: Dai – volume: 74 start-page: 72 issue: suppl 1 year: 2008 ident: 10.1016/j.critrevonc.2019.102831_bib0515 article-title: Controlled-release oxycodone in the treatment of neuropathic pain of nonmalignant and malignant causes publication-title: Oncology. doi: 10.1159/000143223 contributor: fullname: Ong – volume: 132 start-page: 584 issue: 5 year: 2006 ident: 10.1016/j.critrevonc.2019.102831_bib0410 article-title: A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma publication-title: Br. J. Haematol. doi: 10.1111/j.1365-2141.2005.05914.x contributor: fullname: Glasmacher – volume: 24 start-page: 454 issue: 2 year: 2012 ident: 10.1016/j.critrevonc.2019.102831_bib0125 article-title: The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings publication-title: Ann. Oncol. doi: 10.1093/annonc/mds329 contributor: fullname: Cavaletti – volume: 9 start-page: 296- year: 2019 ident: 10.1016/j.critrevonc.2019.102831_bib0580 article-title: Systems biology understanding of the effects of Lithium on Cancer publication-title: Front. Oncol. doi: 10.3389/fonc.2019.00296 contributor: fullname: Ge – volume: 35 start-page: 201 issue: 4 year: 2017 ident: 10.1016/j.critrevonc.2019.102831_bib0115 article-title: Pilot testing a web-based system for the assessment and management of chemotherapy-induced peripheral neuropathy publication-title: Comput. Inform. Nurs. doi: 10.1097/CIN.0000000000000320 contributor: fullname: Knoerl – start-page: Cd005228 issue: 1 year: 2007 ident: 10.1016/j.critrevonc.2019.102831_bib0085 article-title: Interventions for preventing neuropathy caused by cisplatin and related compounds publication-title: Cochrane Database Syst. Rev. contributor: fullname: Albers – volume: 111 start-page: 531 issue: 6 year: 2019 ident: 10.1016/j.critrevonc.2019.102831_bib0040 article-title: The National Cancer Institute Clinical Trials Planning Meeting for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy publication-title: JNCI doi: 10.1093/jnci/djz011 contributor: fullname: Dorsey – start-page: Cd005454 issue: 4 year: 2007 ident: 10.1016/j.critrevonc.2019.102831_bib0455 article-title: Antidepressants for neuropathic pain publication-title: Cochrane Database Syst. Rev. contributor: fullname: Saarto – volume: 24 start-page: 1472 issue: 6 year: 2013 ident: 10.1016/j.critrevonc.2019.102831_bib0240 article-title: CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel† publication-title: Ann. Oncol. doi: 10.1093/annonc/mdt018 contributor: fullname: Hertz – volume: 91 start-page: 135 issue: 2 year: 2005 ident: 10.1016/j.critrevonc.2019.102831_bib0560 article-title: A pilot study on the effect of acetyl-L-carnitine in paclitaxel-and cisplatin-induced peripheral neuropathy publication-title: Tumori. doi: 10.1177/030089160509100206 contributor: fullname: Maestri – volume: 26 start-page: 4696 issue: 11 year: 2012 ident: 10.1016/j.critrevonc.2019.102831_bib0205 article-title: Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment publication-title: FASEB J. doi: 10.1096/fj.12-214643 contributor: fullname: Mo – volume: 232 start-page: 154 issue: 2 year: 2011 ident: 10.1016/j.critrevonc.2019.102831_bib0160 article-title: Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy publication-title: Exp. Neurol. doi: 10.1016/j.expneurol.2011.08.016 contributor: fullname: Zheng – volume: 4 year: 2007 ident: 10.1016/j.critrevonc.2019.102831_bib0010 article-title: Taxanes for adjuvant treatment of early breast cancer publication-title: Cochrane Database Syst. Rev. contributor: fullname: Ferguson – volume: 8 start-page: 10 issue: 1 year: 2009 ident: 10.1016/j.critrevonc.2019.102831_bib0355 article-title: Platinum neurotoxicity pharmacogenetics publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-08-0840 contributor: fullname: McWhinney – volume: 17 start-page: 2734 issue: 9 year: 2011 ident: 10.1016/j.critrevonc.2019.102831_bib0380 article-title: Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-10-1950 contributor: fullname: Arastu-Kapur – volume: 8 start-page: e72995-e issue: 9 year: 2013 ident: 10.1016/j.critrevonc.2019.102831_bib0405 article-title: Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse publication-title: PLoS One doi: 10.1371/journal.pone.0072995 contributor: fullname: Carozzi – volume: 10 start-page: 1489 issue: 9 year: 2009 ident: 10.1016/j.critrevonc.2019.102831_bib0250 article-title: Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies publication-title: Pharmacogenomics doi: 10.2217/pgs.09.82 contributor: fullname: Daily – volume: 291 start-page: 1 issue: 1-3 year: 2012 ident: 10.1016/j.critrevonc.2019.102831_bib0030 article-title: Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy publication-title: Toxicology. doi: 10.1016/j.tox.2011.10.019 contributor: fullname: Jaggi – volume: 263 start-page: 40 issue: 1-2 year: 2007 ident: 10.1016/j.critrevonc.2019.102831_bib0390 article-title: A high-dose bortezomib neuropathy with sensory ataxia and myelin involvement publication-title: J. Neurol. Sci. doi: 10.1016/j.jns.2007.05.023 contributor: fullname: Filosto – volume: 40 start-page: 872 issue: 7 year: 2014 ident: 10.1016/j.critrevonc.2019.102831_bib0285 article-title: Chemotherapy-induced neuropathy: a comprehensive survey publication-title: Cancer Treat. Rev. doi: 10.1016/j.ctrv.2014.04.004 contributor: fullname: Miltenburg – volume: 58 start-page: 1961 issue: 16 year: 2010 ident: 10.1016/j.critrevonc.2019.102831_bib0385 article-title: Pathological adaptive responses of Schwann cells to endoplasmic reticulum stress in bortezomib-induced peripheral neuropathy publication-title: Glia. doi: 10.1002/glia.21065 contributor: fullname: Shin – volume: 11 start-page: 1057 issue: 11 year: 2010 ident: 10.1016/j.critrevonc.2019.102831_bib0370 article-title: Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(10)70206-0 contributor: fullname: Broyl – volume: 2 start-page: 36 issue: 1 year: 2009 ident: 10.1016/j.critrevonc.2019.102831_bib0420 article-title: Mechanism of action of lenalidomide in hematological malignancies publication-title: J. Hematol. Oncol. doi: 10.1186/1756-8722-2-36 contributor: fullname: Kotla – volume: 4 start-page: 6 year: 2018 ident: 10.1016/j.critrevonc.2019.102831_bib0575 article-title: An assessment of neuronal calcium sensor-1 and response to neoadjuvant chemotherapy in breast cancer patients publication-title: NPJ Breast Cancer doi: 10.1038/s41523-018-0057-7 contributor: fullname: Moore – volume: 124 start-page: 593 issue: 2 year: 2010 ident: 10.1016/j.critrevonc.2019.102831_bib0260 article-title: Association of CYP1B1 with hypersensitivity induced by taxane therapy in breast cancer patients publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-010-1034-5 contributor: fullname: Rizzo – volume: 36 start-page: 683 issue: 8 year: 2013 ident: 10.1016/j.critrevonc.2019.102831_bib0305 article-title: [Vincristine-induced unilateral ptosis: case report and review of the literature] publication-title: J. Fr. Ophtalmol. doi: 10.1016/j.jfo.2013.03.007 contributor: fullname: Batta – volume: 10 start-page: 3839 issue: 11 year: 2004 ident: 10.1016/j.critrevonc.2019.102831_bib0375 article-title: Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-03-0561 contributor: fullname: Pei – volume: 74 start-page: 893 issue: 6 year: 2013 ident: 10.1016/j.critrevonc.2019.102831_bib0595 article-title: Ethoxyquin prevents chemotherapy-induced neurotoxicity via Hsp90 modulation publication-title: Ann. Neurol. doi: 10.1002/ana.24004 contributor: fullname: Zhu – volume: 596 start-page: 90 year: 2015 ident: 10.1016/j.critrevonc.2019.102831_bib0020 article-title: Chemotherapy-induced peripheral neuropathy: what do we know about mechanisms? publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2014.10.014 contributor: fullname: Carozzi – volume: 15 start-page: 3081 issue: 29 year: 2008 ident: 10.1016/j.critrevonc.2019.102831_bib0025 article-title: Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies publication-title: Curr. Med. Chem. doi: 10.2174/092986708786848569 contributor: fullname: Park – start-page: 512 year: 2018 ident: 10.1016/j.critrevonc.2019.102831_bib0325 article-title: 51 - adjuvant and neoadjuvant chemotherapy for early-stage nonsmall cell lung cancer contributor: fullname: Scagliotti – volume: 3 start-page: 198 issue: 2 year: 2015 ident: 10.1016/j.critrevonc.2019.102831_bib0290 article-title: Mitochondrial dysfunction in chemotherapy-induced peripheral neuropathy (CIPN) publication-title: Toxics. doi: 10.3390/toxics3020198 contributor: fullname: Canta – volume: 82 start-page: 51 issue: 1 year: 2012 ident: 10.1016/j.critrevonc.2019.102831_bib0110 article-title: Chemotherapy-induced peripheral neurotoxicity (CIPN): an update publication-title: Crit. Rev. Oncol. Hematol. doi: 10.1016/j.critrevonc.2011.04.012 contributor: fullname: Argyriou – volume: 332 start-page: 1004 issue: 15 year: 1995 ident: 10.1016/j.critrevonc.2019.102831_bib0145 article-title: Paclitaxel (taxol) publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199504133321507 contributor: fullname: Rowinsky – volume: 29 start-page: 151 issue: 2 year: 2017 ident: 10.1016/j.critrevonc.2019.102831_bib0415 article-title: Treatment and surveillance of advanced, metastatic iodine-resistant differentiated thyroid cancer publication-title: Curr. Opin. Oncol. doi: 10.1097/CCO.0000000000000349 contributor: fullname: Ibrahim – volume: 67 start-page: 693 issue: 7 year: 2011 ident: 10.1016/j.critrevonc.2019.102831_bib0265 article-title: Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer publication-title: Eur. J. Clin. Pharmacol. doi: 10.1007/s00228-011-1007-6 contributor: fullname: Bergmann – volume: 26 start-page: 1642 issue: 10 year: 2008 ident: 10.1016/j.critrevonc.2019.102831_bib0220 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2007.11.6699 contributor: fullname: Seidman – volume: 89 start-page: 200 issue: 4 year: 2018 ident: 10.1016/j.critrevonc.2019.102831_bib0485 article-title: Effectiveness of gabapentin pharmacotherapy in chemotherapy-induced peripheral neuropathy publication-title: Ginekol. Pol. doi: 10.5603/GP.a2018.0034 contributor: fullname: Magnowska – volume: 14 issue: 8 year: 2019 ident: 10.1016/j.critrevonc.2019.102831_bib0045 article-title: A systematic summary and comparison of animal models for chemotherapy induced (peripheral) neuropathy (CIPN) publication-title: PLoS One doi: 10.1371/journal.pone.0221787 contributor: fullname: Gadgil – volume: 103 start-page: 18356 issue: 48 year: 2006 ident: 10.1016/j.critrevonc.2019.102831_bib0165 article-title: Paclitaxel induces calcium oscillations via an inositol 1, 4, 5-trisphosphate receptor and neuronal calcium sensor 1-dependent mechanism publication-title: Proc. Natl. Acad. Sci. doi: 10.1073/pnas.0607240103 contributor: fullname: Boehmerle – volume: 4 start-page: 1231 issue: 11 year: 2013 ident: 10.1016/j.critrevonc.2019.102831_bib0275 article-title: Vinca alkaloids publication-title: Int. J. Prev. Med. contributor: fullname: Moudi – volume: 12 start-page: 72 issue: 1 year: 2017 ident: 10.1016/j.critrevonc.2019.102831_bib0065 article-title: Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage publication-title: Neural Regen. Res. doi: 10.4103/1673-5374.198986 contributor: fullname: Kelley – volume: 25 start-page: 3485 issue: 11 year: 2017 ident: 10.1016/j.critrevonc.2019.102831_bib0105 article-title: Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey publication-title: Support. Care Cancer doi: 10.1007/s00520-017-3772-y contributor: fullname: McCrary – volume: 20 start-page: 866 issue: 5 year: 2015 ident: 10.1016/j.critrevonc.2019.102831_bib0475 article-title: Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial publication-title: Int. J. Clin. Oncol. doi: 10.1007/s10147-015-0810-y contributor: fullname: Hirayama – volume: 8 start-page: 363 issue: 5 year: 2018 ident: 10.1016/j.critrevonc.2019.102831_bib0140 article-title: An updated understanding of the mechanisms involved in chemotherapy-induced neuropathy publication-title: Pain Manag. doi: 10.2217/pmt-2018-0020 contributor: fullname: Boyette-Davis – volume: 88 start-page: 1942 issue: 12 year: 2003 ident: 10.1016/j.critrevonc.2019.102831_bib0335 article-title: Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6601012 contributor: fullname: Jamieson – volume: 10 start-page: 1 issue: 1 year: 1992 ident: 10.1016/j.critrevonc.2019.102831_bib0550 article-title: Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: a study of the Eastern Cooperative Oncology Group publication-title: Cancer Invest. doi: 10.3109/07357909209032783 contributor: fullname: Wiernik – volume: 25 start-page: 2241 issue: 7 year: 2017 ident: 10.1016/j.critrevonc.2019.102831_bib0070 article-title: Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast publication-title: cancer contributor: fullname: Song – volume: 1865 start-page: 1660 issue: 11 Pt B year: 2018 ident: 10.1016/j.critrevonc.2019.102831_bib0170 article-title: NCS-1 is a regulator of calcium signaling in health and disease publication-title: Biochim. et biophys. acta Mol. Cell Res. doi: 10.1016/j.bbamcr.2018.05.005 contributor: fullname: Boeckel – volume: 155 start-page: 2461 issue: 12 year: 2014 ident: 10.1016/j.critrevonc.2019.102831_bib0055 article-title: Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis publication-title: Pain. doi: 10.1016/j.pain.2014.09.020 contributor: fullname: Seretny – volume: 34 start-page: 322 issue: 7 year: 2016 ident: 10.1016/j.critrevonc.2019.102831_bib0120 article-title: Usability and acceptability of a web-based program for chemotherapy-induced peripheral neuropathy publication-title: Comput. Inform. Nurs. doi: 10.1097/CIN.0000000000000242 contributor: fullname: Tofthagen – volume: 35 start-page: 917 issue: 10 year: 2015 ident: 10.1016/j.critrevonc.2019.102831_bib0540 article-title: Peripherally restricted cannabinoids for the treatment of pain publication-title: Pharmacotherapy. doi: 10.1002/phar.1642 contributor: fullname: Romero-Sandoval – year: 2013 ident: 10.1016/j.critrevonc.2019.102831_bib0235 article-title: S0221: comparison of two schedules of paclitaxel as adjuvant therapy for breast cancer publication-title: Am. Soc. Clin. Oncol. doi: 10.1200/jco.2013.31.15_suppl.cra1008 contributor: fullname: Budd – volume: 42 start-page: 516 issue: 7 year: 2014 ident: 10.1016/j.critrevonc.2019.102831_bib0430 article-title: Immunomodulatory drugs thalidomide and lenalidomide affect osteoblast differentiation of human bone marrow stromal cells in vitro publication-title: Exp. Hematol. doi: 10.1016/j.exphem.2014.03.005 contributor: fullname: Bolomsky – volume: 36 start-page: 27 issue: 1 year: 2017 ident: 10.1016/j.critrevonc.2019.102831_bib0230 article-title: Weekly taxane–anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial publication-title: Chin. J. Cancer doi: 10.1186/s40880-017-0196-5 contributor: fullname: Tan – volume: 116 start-page: 679 issue: 5 year: 2010 ident: 10.1016/j.critrevonc.2019.102831_bib0395 article-title: Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma publication-title: Blood doi: 10.1182/blood-2010-02-268862 contributor: fullname: Richardson – volume: 24 start-page: 4779 issue: 11 year: 2016 ident: 10.1016/j.critrevonc.2019.102831_bib0095 article-title: Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment publication-title: Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. doi: 10.1007/s00520-016-3329-5 contributor: fullname: Zanville – volume: 9 start-page: 7322 issue: 7 year: 2018 ident: 10.1016/j.critrevonc.2019.102831_bib0585 article-title: The prevention of chemotherapy induced peripheral neuropathy by concurrent treatment with drugs used for bipolar disease: a retrospective chart analysis in human cancer patients publication-title: Oncotarget. doi: 10.18632/oncotarget.23467 contributor: fullname: Wadia – volume: 14 start-page: e448 issue: 5 year: 2018 ident: 10.1016/j.critrevonc.2019.102831_bib0490 article-title: Efficacy and safety of oxycodone/naloxone as add-on therapy to gabapentin or pregabalin for the management of chemotherapy-induced peripheral neuropathy in Korea publication-title: Asia. J. Clin. Oncol. doi: 10.1111/ajco.12822 contributor: fullname: Kim – volume: 12 start-page: 1151 issue: 12 year: 2011 ident: 10.1016/j.critrevonc.2019.102831_bib0270 article-title: Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(11)70131-0 contributor: fullname: Cavaletti – volume: 110 start-page: 2110 issue: 9 year: 2007 ident: 10.1016/j.critrevonc.2019.102831_bib0510 article-title: Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3) publication-title: Cancer. doi: 10.1002/cncr.23008 contributor: fullname: Rao – volume: 20 start-page: 396 issue: 5 year: 2009 ident: 10.1016/j.critrevonc.2019.102831_bib0545 article-title: Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity publication-title: Anticancer Drugs doi: 10.1097/CAD.0b013e32832a2dc1 contributor: fullname: Milla – volume: 10 start-page: 174- year: 2017 ident: 10.1016/j.critrevonc.2019.102831_bib0315 article-title: Pathophysiology of chemotherapy-induced peripheral neuropathy publication-title: Front. Mol. Neurosci. doi: 10.3389/fnmol.2017.00174 contributor: fullname: Starobova – volume: 6 start-page: 28861 year: 2016 ident: 10.1016/j.critrevonc.2019.102831_bib0590 article-title: Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity publication-title: Sci. Rep. doi: 10.1038/srep28861 contributor: fullname: Zhu – volume: 11 issue: 481 year: 2017 ident: 10.1016/j.critrevonc.2019.102831_bib0330 article-title: A mechanistic understanding of axon degeneration in chemotherapy-induced peripheral neuropathy publication-title: Front. Neurosci. contributor: fullname: Fukuda – volume: 30 start-page: 1020 issue: 11 year: 2016 ident: 10.1016/j.critrevonc.2019.102831_bib0520 article-title: New practical approaches to chemotherapy-induced neuropathic pain: prevention, assessment, and treatment publication-title: Oncology (Williston Park, N.Y.) contributor: fullname: Majithia |
| SSID | ssj0004467 |
| Score | 2.59198 |
| SecondaryResourceType | review_article |
| Snippet | •Chemotherapy induced peripheral neuropathy is a common progressive, and often irreversible, adverse effect of many chemotherapeutic agents.•Currently, there... Chemotherapy-induced peripheral neuropathy (CIPN) is an adverse effect of chemotherapy that is frequently experienced by patients receiving treatment for... |
| SourceID | pubmedcentral crossref pubmed elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 102831 |
| SubjectTerms | Antineoplastic Agents - adverse effects Bortezomib - adverse effects Chemotherapy CIPN Cisplatin Humans Neoplasms - drug therapy Neuropathy Oxaliplatin Paclitaxel Peripheral Nervous System Diseases - chemically induced Taxanes Taxoids - therapeutic use Vinca alkaloids |
| Title | Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings |
| URI | https://dx.doi.org/10.1016/j.critrevonc.2019.102831 https://www.ncbi.nlm.nih.gov/pubmed/31783290 https://pubmed.ncbi.nlm.nih.gov/PMC6982645 |
| Volume | 145 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELaqIiEWxJvyqDywps3DSWyYqoqqgNqFVuoWxY4NRZBUJSB14bdzdpKWTCCxJnZifWffw3f-jNAVIyJQcaIvzVDEIoIzK44Zt0IuA5upkFGh9ztG42A4Jfczf9ZA_eosjC6rLHV_odONti6fdEs0u4v5vPsIgYRNiU4EeWCoTAhEwBjBnO58bco8INwJC0YC29Kty2qeosYLFma-lJ9ZqskMHdYx1tb51UTVyyd_2KPBHtotHUncK8a6jxoyPUDbozJVfoimFTlTluJMYZDNW3nYamVBHA4STbBmOTa0Aq_Y8Frq64lX17iHiwMtuh-AAx_BJrWdPr0focngdtIfWuUdCpYA3yi3FNWJRRV6ynUSwQlL_IAo14NlSQSjdgIhqvBFCFAqmyvOFQ0C7gvuq5Bz3ztGzTRL5SnC1KN-EFNJhOT6mmoqZCxZwqlQSrhMtpBToRYtCqaMqCohe4k2SEca6ahAuoVuKnijmtQjUOh_6H1SCGL9P3CGQEMxu4XCmojWDTSZdv1NOn82pNoBg0CL-Gf_GtE52nF1PG62aC5QM19-yEtwWnLeNrOyjbZ6dw_D8TfjnPEG |
| link.rule.ids | 230,315,786,790,891,4521,24144,27957,27958,45620,45714 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELaqIgEL4k15emBNmzROYsNUVVQF2i60UrcodmwogrQqBakLv527PAqZQGJN7CT6Lr6H7_wdIZeCKd9EMTbNMMxiSgorioS0Aql9W5hAcIX7Hf2B3x2xu7E3rpB2cRYGyypz3Z_p9FRb51caOZqN2WTSeIBAwuYME0EuGCoMgdbQncf-DfXP7zoPiHeCjJLAtnB4Xs6TFXnBylzM9cc0QTZDR9RTc-v8aqPK9ZM_DFJnm2zlniRtZR-7Qyo62SXr_TxXvkdGBTvTNKFTQ0E4r_lpq6UFgTiINKZIc5zyCrzQlNgS-xMvr2iLZidacB6gAw-haW47eXzbJ8POzbDdtfImCpYC52hhGY6ZRRO4punESjIRez4zTRfWJVOC2zHEqMpTAWBpbGmkNNz3paekZwIpPfeAVJNpoo8I5S73_IhrprTEPtVc6UiLWHJljGoKXSNOgVo4y6gywqKG7Dn8RjpEpMMM6Rq5LuANS2IPQaP_YfZhJojV-8AbAhUl7BoJSiJaDUA27fKdZPKUsmr7AiIt5h3_64suyEZ32O-FvdvB_QnZbGJwnu7XnJLqYv6uz8CDWcjz9A_9AnHl8pg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevention+of+chemotherapy-induced+peripheral+neuropathy%3A+A+review+of+recent+findings&rft.jtitle=Critical+reviews+in+oncology%2Fhematology&rft.au=Ibrahim%2C+Eiman+Y.&rft.au=Ehrlich%2C+Barbara+E.&rft.date=2020-01-01&rft.issn=1040-8428&rft.volume=145&rft.spage=102831&rft_id=info:doi/10.1016%2Fj.critrevonc.2019.102831&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_critrevonc_2019_102831 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1040-8428&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1040-8428&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1040-8428&client=summon |